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Many accidental deaths have recently occurred in Indiana due to opioid overdose. The 
current study sought to assess the association between sociodemographic factors, health 
insurance, and successful treatment completion for opioids abusers in Indiana based on 
the existing literature gap. In this study, the dependent variables considered were 
treatment completion status and opioid abuse. The independent variables included health 
insurance coverage and sociodemographic factors of education, marital status, 
employment status, race, gender, and age. I measured both dependent and independent 
variables as categorical. A cross-sectional and quantitative research approach was used 
by analyzing data from the 2017-Treatment Episode Data Set Discharges (TEDS-D) 
using the Statistical Package for the Social Sciences (SPSS) version 25.0.Descriptive 
statistics, chi-square, bivariate, and multivariate logistic regression were applied to 
evaluate the association. Significant findings revealed that individuals in “not in labor 
force” were 2.0 times more likely [OR=2.042, 95% CI (1.853, 2.252), p<0.0001], 
unemployed were 1.8 times more likely [OR=1.785, 95% CI (1.662, 1.916), p<0.0001], 
and part-timers were 1.4 times more likely [OR=1.406, 95% (1.269, 1.557), p<0.0001] to 
complete treatment compared to full-time workers. The outcomes showed that compared 
to insured, uninsured individuals were less likely [OR=0.704, 95% CI (0.662, 
0.749), p<0.0001] to complete treatment. Intervention plans such as increasing screening 
among vulnerable populations, mass education, and advocacy for health insurance 
coverage could promote positive social change by decreasing opioid-related mortality and 
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Chapter 1: Introduction to the Study  
The World Drug Report of 2018 stated that opioid usage was at the highest level 
in recorded history and became is a major concern due to increased drug prescription 
misuse and the use of illegal opioids. The report found that prescription drug use has 
become a significant menace to public health and law enforcement agencies across the 
world. It showed that opioids cause the most harm with a mortality rate of 76 % where 
drug use disorders were involved (The United Nations Office on Drugs and Crime or 
[UNODC], 2018). Substance abuse, including alcohol, illicit drugs, and prescription 
drugs, persists and has become a significant health problem worldwide (Chakravarthy et 
al, 2013). Nearly 5% of the world's population used an illegal drug in 2010, and estimates 
revealed that 27 million individuals (0.6 % of world adult population) are considered 
problem drug users (Chakravarthy et al., 2013). Researchers have shown that alcohol 
alone claimed the lives of 2.5 million yearly while that heroin, cocaine, and other drugs 
were accounted for 0.1 to 0.2 million deaths each year. Substance abuse causes 
significant morbidity, while the treatment of drug addiction represents a real social 
burden (Chakravarthy et al., 2013). According to UNODC, the total costs for drug abuse 
treatment have been estimated to reach between $200-$250 billion, which constitutes 
about 0.3-0.4 % of world GDP (Chakravarthy et al., 2013). Researchers found that only 
20% of drug users were admitted for treatment of drug dependency in 2010 
(Chakravarthy et al., 2013). A report indicated that individuals who used drugs at least 
once a year in 2016 were aged 15-64 years old, accounting for 275 million people 




The use of addictive substances and the upsurge in drug abuse, along with its 
underlying health effects, have emerged as one of the prominent public health problems 
(Chaturvedi et al., 2009; Gomes et al., 2018). Additionally, over the past decades the use 
of medical and nonmedical prescription of opioids has become a growing concern in the 
United States (Bolshakova et al., 2018; Gomes et al., 2018; Lowder et al., 2018; McCabe 
et al., 2017; Meyer et al., 2014; Oderda et al., 2015; Wisniewski et al., 2008).  However, 
researchers have indicated a marked decline in the use of medical and nonmedical 
opioids’ prescription in recent years (Kolodny et al., 2015). The Centers for Disease 
Control and Prevention (CDC) stated that more than 190 million opioid-related 
prescriptions were supplied to American citizens in 2017 with wide variation among 
states. Despite government restrictions, the use of illicit drugs (e.g., heroin, cocaine) and 
other substances legally obtained (e.g., oxycodone, hydrocodone) has risen to an 
alarming level in the United States and particularly in Indiana. Because of the abuse, 
many thousands of people have overdosed and died. Additionally, statistics from the 
National Center for Health Statistics (NCHS) show that more than 70,000 people died in 
2017 alone. It is estimated that an average of 130 United States citizens die every day 
because of opioid abuse (CDC, 2017). Furthermore, Gomes et al. (2018) noted the 
disability-adjusted life-years (DALYs) due to years of life lost (YLL) at over 800,000 for 
people under 65 years old in the United States as a result of opioid overdose. Opioid 
prescription abuse can lead to overdose, addiction, and substance abuse disorder (Han et 




In the state of Indiana,74, 000 people have abused opioids in 2017 (Brewer, 
2018). About 1,700 Indiana residents died because of overdose (Richard Fairbanks 
Foundation, 2018). The populations most affected were individuals aged 25-34 years and 
35-44years old, and males were more vulnerable than females (Gomes et al., 2018). 
According to the U.S Census Bureau (2018), Indiana State is home to 6,732,219 
residents, with 51.86 % female and 48.14% male and racial groups are composed of 54.8 
% Whites, 28.9% African Americans, 10.6% Latinos, 3.6% Asians, and 2.1% of Native 
Americans, Alaskans, Hawaiians, and Pacific Islanders. Among the populaces, about 
30% have earned a bachelor's or higher, and the remainders have a high school degree. 
The median household income in Indiana was estimated at $ 47,642. (U.S. Census 
Bureau, 2018). While females and males without employment were 47% and 39%, 
respectively (U.S. Census Bureau, 2018). The state of Indiana has implemented plans to 
counter the problems of opioid abuse and its health consequences, but despite that, the 
issue kept growing.  
Several researchers at treatment centers have investigated opioid abuse and its 
correlations with opioid misuse. A growing body of evidence suggested that 
sociodemographic profiles influenced opioid abuse (Farhat et al., 2015; Gul & Sharma, 
2017; Lamptey, 2005; Ranjan et al., 2010; Rather et al., 2013; Simoni-Wastila& 
Strickler, 2011; Swendsen et al., 2009; Tavares et al., 2004). For instance, researchers 
have shown that divorced marital status, unemployment, and place of residence are 
significantly related to drug abuse (Tavares et al., 2004). Additional factors highly linked 




levels, and living in rural areas (Gul & Sharma, 2017). Ray et al. (2017) found in their 
study that respondents aged under 40 years old, and male were strongly correlated with 
opioid abuse. Despite these findings and the implementation of many programs targeting 
these variables, the problem of opioid abuse continues to amplify. 
 This cross-sectional and quantitative study design should be conducted to 
improve the burden of opioid abuse in Indiana. The purpose of the present study was to 
assess the potential relationship between sociodemographic factors, health insurance, and 
successful treatment completion for opioids abusers in Indiana. The outcomes of the 
study could promote positive social change by expanding health insurance coverage, 
improving treatment outcomes, and by reducing morbidity and mortality rates due to 
opioid abuse. In the current chapter, I will discuss the purpose, background, nature, and 
significance of the study, the problem statement, research questions, and hypotheses. This 
chapter will also include the theoretical foundation and conceptual framework used, its 
assumptions, and limitations. 
Background of the Study 
Opioid prescriptions abuse has emerged as a leading public health concern both 
globally and nationwide (Bolshakova et al., 2018; McHugh et al., 2014; Oderda et al., 
2015). It has been well documented that the use of medical and nonmedical prescription 
of opioids has increased in the United States for many decades (Bolshakova et al., 2018; 
Han et al., 2017; McCabe et al., 2017). In 2004, researchers suggested that approximately 
2.5 million individuals aged 12 and older had used nonmedical prescription of pain 




nonmedical prescriptions of opioids have surged to 53%and have become accessible for 
individuals to use (Tetrault& Butner, 2015). Several researchers also discussed the 
upsurge of medical prescription of opioid in recent years. Meyer et al. (2014) reported 
large increases in methadone, oxycodone, and hydrocodone prescriptions with 933%, 
588%, and 198%, respectively. Furthermore, a survey by Han et al. (2017) indicated that 
roughly 92 million adults used prescription opioids within the past year and about 12 
million of them abused them. The use of illicit prescription opioids has become more 
fatal (Morales et al., 2019). 
Opioid prescription abuse is a significant public health dilemma and can lead to 
substance abuse disorder and overdose (Bolshakova et al., 2018, and Han et al., 2017; 
McCabe et al., 2017). Recently, Kolodny et al. (2015) noted that people needing 
addiction treatment because of OPRs rose to a daunting number of 900%. Gomes et al. 
(2018) noted that opioid overdose had claimed more than 800,000 lives under 65 years 
old in the United States. In another survey, researchers revealed that about 75% of the 
total overdose fatalities were due to prescription opioids (Florence et al., 2016). Morales 
et al. (2019) estimated the overdose-related mortality in 2017 to reach more than 70,000 
people. The burden of opioid abuse continues to grow, despite massive government 
spending in healthcare. In Indiana, opioid overdose claimed the lives of over 1700 people 
(Richard Fairbanks Foundation, 2018). 
According to Meyer et al. (2007), the total medical costs related to prescription 
abuse was estimated at $55.7 billion annually. Florence et al. (2016) estimated this figure 




were significantly associated with prescription opioid abuse (Farhat et al., 2015; Gul & 
Sharma, 2017; Lamptey (2005); Ranjan et al., 2010; Simoni-Wastila& Strickler, 2011; 
Swendsen et al., 2009; Tavares et al., 2004). Researchers revealed that younger people 
aged 15-24 years and 25-44 years old were the most vulnerable (Gomes et al., 2018). 
Despite these studies and the implementation of various recommendations, the epidemic 
of prescription opioid abuse continues to grow. There was a limited research on health 
insurance coverage and treatment completion for opioids abuse, and this cross-sectional 
and quantitative study intended to fill the gap. This study is needed to expand health 
insurance coverage and improve treatment outcomes while reducing morbidity and 
mortality rates due to opioids abuse in Indiana. 
Problem Statement 
The upsurge of prescription opioid abuse and its emergence as a leading public 
health problem had been well documented (American Health and Drug Benefits or 
AHDB, 2015). In 2007, an estimated 5.2 million individuals aged 12 years and older had 
been reported to abuse prescription opioids during the past month. About 2.1 million of 
them initiated nonmedical prescription of opioids (AHDB, 2015). The use of nonmedical 
prescription opioids had also climbed sharply and had shown to be very dangerous 
because it could lead to addiction and death (AHDB, 2015). The total costs related to 
opioid prescription abuse also soared significantly. Birnbaum et al. (2011) noted that the 
total projected U.S. expenditure linked to opioid prescription abuse was $55.7 billion in 
2007 including $25.6 billion (46%) for workplace, $25.0 billion (45%) for health care 




Morbidity and mortality related to opioid prescriptions increased dramatically in 
recent years (Miller et al., 2018). During 2014 and 2015, the number of fatalities linked 
to drugs accounted for 52,404 deaths nationwide, in which 63.1% involved opioid use 
(Seth et al., 2018). People aged 24-45 years old were more vulnerable than other age 
groups (Gomes et al., 2018). Some toxicology tests on unknown sudden deaths have 
revealed that 86.0% were tested positive to opioid, shifting the mortality rate to 86.0% 
from 34.2% (Lowder et al., 2018). Data show that individuals aged 18 to 25 years old are 
more vulnerable than other groups (NIDA, 2018). Many efforts had been implemented to 
curb the epidemic, but the problem continues to grow unabated. Various studies focused 
on sociodemographic factors, but few of them are specifically from Indiana, a state of 
6.692 million people. Additionally, previous studies failed to evaluate the recently 
implemented strategies, which may play a role in the intensification of this opioid 
prescription abuse. There is limited research that evaluated opioid abusers’ health 
insurance status associated with their treatment outcomes. Researchers suggested that 
individuals with better insurance coverage are more likely to receive specialty substance 
abuse treatment than those who are uninsured (Cummings et al., 2014). This cross-
sectional and quantitative study aimed to assess the association between 
sociodemographic factors, health insurance coverage, and treatment completion for 
opioids abusers using the Treatment Episode Data Set – Discharges (TEDS-D). The 
conclusions of this study could help design policies to expand insurance coverage and to 
improve opioid treatment outcomes. This could improve morbidity and mortality rates 




Purpose of the Study 
Researchers have found that inappropriate use of physicians’ prescription of pain 
relievers, lack of training, and lack of cooperation among federal agencies are among the 
main factors that lead to opioid abuse. Additionally, sociodemographic factors play a 
significant role in the epidemic. Many efforts have been implemented but failed to curb 
this growing public health concern of prescription opioid abuse. This cross-sectional and 
quantitative approach aimed to examine the correlation between sociodemographic 
factors (age, gender, race, education status, marital status, and employment status), health 
insurance coverage, and treatment completion outcomes for opioid abusers in Indiana 
using the TEDS-D.  The primary dependent variable was “treatment completion” and the 
dependent variable was “opioids abuse” or “opiates/synthetics abuse.” The exposure or 
predictor variables were sociodemographic factors (age, gender, race, education status, 
marital status, and employment status) and health insurance coverage. 
Research Questions and Hypotheses 
Research Question 1: Is there any association between sociodemographic factors 
and opioid abusers among residents in Indiana?  
H01: There is no association between sociodemographic factors and opioid 
abusers among residents in Indiana. 
Ha1: There is an association between sociodemographic factors and opioid 
abusers among residents in Indiana 
Research Question 2: Is there any association between health insurance coverage 




H02: There is no association between health insurance coverage and treatment 
completion for opioid abusers in Indiana 
Ha2: There is an association between health insurance coverage and treatment 
completion for opioid abusers in Indiana 
Research Question 3: Is there any association between health insurance coverage 
and treatment completion for opioid abusers in Indiana after controlling for 
sociodemographic factors? 
H03: There is no association between health insurance coverage and treatment 
completion for opioid abusers in Indiana after controlling for sociodemographic factors 
Ha3: There is an association between health insurance coverage and treatment 
completion for opioid abusers in Indiana after controlling for sociodemographic factors 
Sociodemographic factors were also adjusted to assess their relationship with 
treatment completion when controlling for age, gender, race, marital status, employment, 
and education level. The dependent or outcome variables considered in this study were 
“treatment completion” and “opioids abuse or opiates/synthetics abuse.” They were both 
measured as categorical variables. The independent or predictor variables were 
“sociodemographic factors” and health insurance coverage and were both measured as 
categorical. 
Theoretical Foundation 
Social cognitive theory (SCT) seemed the most appropriate in this quantitative 
cross-sectional study. SCT was invented by Bandura in 1986 (Glanz et al., 2015). The 




to determine motivation and behavior (Weaver, 2016). Glanz et al. (2015) noted that SCT 
had been applied to understand ways individuals may learn about risky behaviors. The 
model had also been used to attain individual and group-level behavioral changes (Glanz 
et al., 2015). SCT is an essential public health tool for promoting health and had been 
effective in managing addictive behavior such as tobacco and alcohol (Glanz et al., 
2015). SCT describes that human behavior is generally motivated and regulated by the 
persisting application of self-influence (Glanz et al., 2015). In Bandura's complete 
description of SCT, human behavior is elucidated as a triadic and dynamic model of 
causation through which behavior, personal cognitive factors, and socioenvironmental 
impacts all interact as reciprocal determinism (Glanz et al., 2015). The self-regulative 
mechanism functions using one’s self-monitoring, its determinants, and its effects. Self-
regulation also embraces one’s self-efficacy, which can promote personal entity through 
its vigorous impact on thought, motivation, and action (Glanz et al., 2015). The proposed 
framework had been widely employed to describe the mechanisms by which individuals 
learn about risky behaviors. Additionally, the model had been used in the initiation and 
the achievement of individual and group-level behavioral goals and had been effective in 
community health promotion strategies (Glanz et al., 2015). For instance, the model of 
SCT had been applied by Tze et al. (2012) to learn about youths' substance drug abuse 
behaviors and to propose school-based programs to help them resist the drug. The SCT 
will be applied in the study to help understand how personal behavior and 




Nature of the Study 
The most appropriate research design for this secondary data analysis is a cross-
sectional and quantitative study. The rationale for selecting this design was that data in 
the TEDS-D were collected at one point. An advantage of this type of study, as reported 
by Sedgwick (2014) is that it allowed the investigator to estimate the prevalence of 
behavior, which had the potential to drive resources allocation and planning 
interventions. Also, cross-sectional studies are generally quick, easy, and cheap to 
conduct, and there will be no missing participants to follow-up because they are 
interviewed once by using a questionnaire survey (Sedgwick, 2014). However, care is 
needed if diverse enrollees are included at each time point. It might be hard to evaluate if 
variations in prevalence reflect a trend or change between different groups of participants 
selected from the population being studied (Sedgwick, 2014). The SCT of Bandura will 
be the primary guiding principle of this cross-sectional research approach. A quantitative 
method will enable the investigator to display data informing about the association 
between sociodemographic factors, health insurance, and treatment completion for opioid 
abusers in Indiana. In this study, the outcome variables were “treatment completion” and 
“Opioid abuse or opiates/ synthetics abuse” and were both categorical. Predictor or 
exposure variables were sociodemographic factors and health insurance coverage, and 
both were measured on the categorical level. A survey from the 2017 TEDS-D will be 
used and descriptive statistics, Chi-square analysis, and multivariate logistic regression 





Agonists: Are medications designed to activate some receptors in the brain (Indian 
Health Service [IHS], n.d). There exist full and partial agonists. Heroin, oxycodone, 
methadone, hydrocodone, morphine, and opium are examples of full agonists (IHS, n.d). 
Whereas buprenorphine is an illustration of partial agonist (IHS, n.d). 
Antagonists: Are medications that have the potential to block opioids by attaching 
them to the receptors without causing any opioid effects. Naltrexone and naloxone are 
good examples of antagonists. 
Analog: Medicines that have similar chemical structure with another medicine, 
but are not identical (CDC, 2019).  
Chronic pain: refers to pain that persists up to 3 months or more and such pain 
can be triggered by an event, condition, injury, treatment, or it can be unknown (CDC, 
2019). 
Drug abuse: refers to illegal use of drugs or prescription drugs intended for other 
purposes and not directed by a physician, often in greater amounts, longer than expected, 
and most often by someone else’s prescription (CDC, 2019). 
Drug addiction: Drug addiction refers to the persistent chronic use of drug 
regardless of serious negative socioeconomic and health consequences and is related to 
loss of control over drug use (Cami and Farre, 2003). 
Drug dependence: refers to constant use of drug, triggering the neurons to be 
accustomed to so that they can only function when the drug is present. When the drug is 




case of caffeine) to potentially life-threatening situations (in the case heroin) (NIDA, 
2019]. 
Fentanyl: Pharmaceutical drug (synthetic opioid) designed to treat severe pain 
such as in advanced cancer. The drug is 50 to 100 times more powerful than morphine. 
Nonetheless, there exist illegal made fentanyl which can be sold on black markets 
generating heroin-like effect to users, but can be dangerous and very fatal (CDC, 2019). 
Fentanyl analogue: Fentanyl analogues are drugs manufactured clandestinely and 
synthesized to yield similar psychotropic reactions to regular fentanyl, but come with 
slightly different molecular structures, making the screening more challenging for the 
investigator (Cabrices et al., 2018). 
Heroin:  Aprohibited and very addictive opioid drug that is processed from 
morphine and obtained from some poppy plants (CDC, 2019). 
Illicit drugs: The non-medical drugs that remain illegal by law. There are many 
drugs, and it includes amphetamine, marijuana/cannabis, cocaine, heroin, other opioids, 
and synthetic drugs like illicitly manufactured fentanyl (IMF) and ecstasy (CDC, 2019). 
Licit drug: non prohibited drugs and it includes drugs prescribed by a physician 
including the recipient’s instruments for whom the drug is intended to, and this also 
incorporates drugs used for treatment of a disease and over the counter medicines when 
they are used appropriately (Brecher, 2016). 
Long-Term residential treatment: Health service that provides care for 24 hours 
daily, often in non-hospital setting, and with concerned individuals willing to stay for 




Morbidity rate: Morbidity refers to any subjective or objective departure, from a 
state of physiological or psychological well-being. It involves disease, injury, and 
disability, and focuses on the number of sick people. Sometimes, this can be referred to 
the periods of sickness that these individuals experienced, or the length of their sickness 
(CDC, 2012). 
Mortality rate: this is referred to the measure of the frequency of occurrence of 
loss of life in a specified population within a specific time (CDC, 2012). 
Narcotic drugs: this term referred to any substance that is intended to relieve pain. 
The term is sometimes applied to all prohibited drugs but theoretically, the term is merely 
referred to opioids. Now opioid becomes the ideal term to avert confusion (CDC, 2019.). 
Nonmedical use: the use of any prescriptions prescribed by a physician, 
prescription drugs that are diverted (drugs not intended to another person to use), for any 
purpose, in any amounts, or in specified time-period the drug is prescribed (CDC, 2019). 
Opioids: refers to a class of medicines that involves prohibited drugs such as 
cocaine, heroin, synthetic opioids (e.g., fentanyl,) and pain killers that are available by 
medical prescription (e.g. oxycodone, hydrocodone, codeine, morphine, and lots of others 
designed to lessen the intensity of body pain. Opioids’ prescriptions are usually safe 
when used in short period of time and when the prescription is used as instructed by a 
physician. Nonetheless, because such prescriptions trigger euphoria besides their pain 




Opioid abuse: the term is generally applied when one’s body tends to adjust its 
regular operation or functioning towards routine use of opioid. Some unpleasant 
symptoms can appear when the person is no longer using the drug (CDC, 2019). 
Opioid overdose: the use of opioids can affect the brain that controls the 
respiratory system. As a result of taking greater amount of opioids, this leads overdose, 
which can slow down the respiration process, and in some cases can stop it suddenly, 
which can lead to death (MedlinePlus, 2019). 
Opioid use disorder (OUD): the term refers to usual or abnormal pattern of opioid 
use that can trigger body impairment. A person is considered to have OUD after 
unsuccessful efforts or attempts to reduce or curb its use, or when the excessive use of the 
drugs can result in many social troubles including absenteeism at workplace, school, or 
prevent a person to fulfill normal obligations at home. The term “opioid use disorder or 
OUD” is ideal term, especially when used with similar definitions, “opioid abuse or 
dependence” or “opioid addiction (CDC, 2019). 
Prescription diversion: Prescription drug diversion is an illegal channeling of 
regulated pharmaceutical substance or drugs from lawful sources to illegal marketplace 
(Wood, 2015). 
Prescription opioids: People use prescription opioids to treat or overcome 
moderate-to-severe pain and these prescriptions are often recommended after surgery or 





Short-Term residential treatment: the term short-term residential treatment 
involves intensive but somewhat short treatment related to a modified 12-step approach. 
The conventional residential treatment model entailed a 3- to 6-week inpatient treatment 
(hospital-based) which is followed by a prolonged outpatient rehabilitation that 
necessitates focus group participation (NIDA, 2018). 
Sociodemographic factors:  It is referred to a group defined by 
its sociological and demographic profile. It looks at the life around individuals’ 
characteristics such as age, gender, one’s sexuality, race, religion, income, matrimonial 
status, birth rate, death rate, average size of family, heritage, level of education, medical 
history and so on. It is basically a grouping of people by those characteristics (Stone, 
2016). 
Substance abuse:  refers to the use of psychoactive substance or drugs that can 
provoke harm or causes hazardous effects on the affected individuals, including people 
who use alcohol and illicit drugs (WHO, 2020). 
Substance dependence: the term substance dependence refers to one’s inability to 
function without the use of an illegal drug or substance. This state is indicative of body 
impairment under the use of illicit substances (APA, 2000). 
Substance use disorder refers to a state of brain impairment that causes a person’s 
inability to control the use of a lawful or unlawful substance or medicine. Among others 




Treatment intervention: the term treatment intervention refers to the coherent and 
accurate conceptualization of health services delivery, and such treatment is used as 
planned (Hart, 2009). 
Assumptions 
In this cross-sectional and quantitative research, it is assumed that substance 
abuse is understood and successfully cured when the person involved (user or abuser) is 
judged in the context of one’s family unit or in a secure living group. This point of view 
is considered vital in the protection of individual from substance abuse, and this 
viewpoint is assumed in the study. It is also assumed that behavioral patterns, attitudes, 
beliefs, and values in the society are discernable and that participants understand and 
share these patterns.  Additionally, it is accepted that the recorded responses or answers 
in the TEDS-D survey were the most straightforward and honest. Moreover, it is assumed 
that participants in this cross-sectional survey understood well the idea of substance 
abuse and its underlying consequences like substance abuse disorder (addiction). 
Scope and Delimitations 
For this survey, the emphasis was put on the various sociodemographic factors 
that might be connected to opioid abuse along with health consequences, including 
overdose, addiction, and substance use disorder. This survey's sociodemographic factors 
are defined as age, gender, race, marital status, education, and employment status. Using 
TEDS-D, the variables included in this analysis were sociodemographic factors, health 
insurance status, and treatment completion for opioid abusers in Indiana. This study 




Treatment Episode Data Set -Discharges or TEDS-D were employed to carry out this 
analysis. It is a national survey instrument that collects subjects' substance abuse 
information, including demographics, admissions, and discharges. Information gathered 
in the TEDS was accurate, and all states and local jurisdictions receiving federal funding 
participate in the survey. The researcher extracted Indiana information from the TEDS 
for analysis of the variables of interest. It appeared that such data contain fewer missing 
cases making the data more reliable. But the researcher will use multivariate regression 
analysis to minimize potential bias from the TEDS.  
Limitations 
This cross-sectional survey might not be conducted without limitations. Because 
of the nature of data collection, information bias might be introduced via participant self-
report. Self-reporting, a widely used approach for gathering data, and requires 
participants to respond to the researcher’s questions without any interference. Self-
reporting data represents a problem for most research design, including cross-sectional’s 
(Althubaiti, 2016). Substance Abuse and Mental Health Services Administration 
[SAMHSA] (2019) reported that external factors such as lack of funding could influence 
this study's validity. It has been shown that states receiving higher funding tend to admit 
many substance abusers for treatment (SAMHSA, 2019). Some states also reported more 
admissions for the same person, which means information gathered represented 
admissions instead of the patient (SAMHSA, 2019). Nonetheless, some missing data 
were recorded in Indiana. Statistical analyses such as multivariate regression will be 




Significance of the Study 
The relationship between sociodemographic factors, opioids abuse, and the 
resulting health consequence of opioid use disorder has been well established (Tavares et 
al., 2004; Lamptey (2005); Swendsen et al., 2009; Ranjan et al., 2010; Simoni-Wastila& 
Strickler, 2011; Farhat et al., 2015; and Gul & Sharma, 2017).  A mountain body of 
evidence suggested that prescription opioid abuse can be deadly. Opioid overdoses 
claimed over 70,237 people in 2017 alone, and 2/3 of them (47, 600) implicated opioids 
(CDC, 2019). Common licit drugs used in opioid overdose mortality include Methadone, 
Oxycodone, and Hydrocodone (CDC, 2017). Also, data showed that illegal drugs, 
including methamphetamines, fentanyl, and heroin, play a deadly role, too (NIDA, 2019). 
The prevalence of fatal opioid overdoses in Indiana claimed 1,104 lives in 2018 (Richard 
Fairbanks Foundation, 2018). Individuals aged 18 years old and over were more 
vulnerable than any groups (NIDA, 2018). About $ 56 billion were spent yearly in 
prescription of opioid misuse or abuse in the U.S (Birnbaum et al., 2011). To date, few 
researchers have assessed the association between health insurance and treatment 
outcomes. This cross-sectional survey aimed to fill the gap. When the study is completed, 
and its recommendations are implemented, it will promote positive social change by 
expanding substance users' coverage and improving their treatment outcomes in Indiana. 





Implications for Positive Social Change 
When this cross-sectional study is completed, the outcomes might have several 
practical implications for positive social change. The findings could improve healthcare 
professionals' knowledge about specific sociodemographic factors contributing to opioid 
abuse while increasing opioids abuse screening in clinical settings in Indiana. The results 
provide an opportunity for health professionals to target those most vulnerable by raising 
awareness. Moreover, the study's completion would enable policymakers to expand 
health insurance coverage for substance abusers who are uninsured or underinsured. 
Additionally, this research could help facilitate access to treatment centers for drug 
abusers. Most importantly, the results can lay the foundation for increased cooperation 
among services to tackle the epidemic of prescription opioid abuse and reduce morbidity 
and mortality due to opioids. 
Summary and Transition 
Prescriptions of opioid have become one of the leading public health problems in 
the United States and in Indiana. It has been demonstrated that opioid abuse can lead to 
fatal overdose and substance abuse disorder. More than 2/3 of individuals who overdose 
involve opioids. Evidence also suggested that the total healthcare expenditure due to 
opioids were estimated at $ 55 billion annually. Sociodemographic factors have shown to 
be linked to opioids abuse. Few studies have been conducted about insurance coverage 
and treatment completion for opioid abuse. This study will fill the gap and assess the 
correlation between insurance coverage and treatment completion. The outcomes of the 




in Indiana. Various intervention plans have been put forth to tackle this growing issue of 
opioid abuse. Despite this, the problem continues to grow unabated. The next chapter 
(chapter 2) will offer an overview of literature review including (a) scope of prescription 
drug abuse, (b) burden of opioid abuse, (c) sociodemographic characteristics and opioid 
abuse, (d) health insurance and substance abuse treatment (e) research involving drug 





Chapter 2: Literature Review 
Opioid abuse has been a long-standing public health issue that the United States 
faces for many years. The societal cost burden of opioid misuse was estimated at $78.5 
billion in 2013, and the number continues to grow since (Florence et al., 2016).As of 
2013, nearly 2 million individuals reported prescription opioid abuse in the U.S. 
(Florence et al., 2016).It is widely recognized that prescription drug abuse or misuse has 
been expanding dramatically nationwide during the last decade, and younger adults aged 
18 to 25 years remain the most vulnerable. It has been documented that licit prescription 
drug such as hydrocodone and oxycodone are the most misused substances among young 
adults. The use of prohibited substances including heroin, cocaine, methamphetamine, 
and fentanyl has also been shown to be rising over recent decades (Chaturvedi et al., 
2009). Schrager et al. (2014) noted that prescription of opioids has become a growing 
public health problem because its abuse or misuse has demonstrated to have a host of 
negative health consequences like fatal opioid overdoses.  
Similar opioid abuse trend has been seen in Indiana despite spending $43 billion, 
and implementating local government restrictions on opioid prescription  (Richard 
Fairbanks Foundation, 2018). In 2017, the overdose-related fatalities in Indiana were 
estimated at 1,700 deaths (Richard Fairbanks Foundation, 2018). In the same year, an 
estimated 355 people died from overdose and the bulk of it was attributed to opioids 
(Richard Fairbanks Foundation, 2018). The main purpose of this quantitative research 
study is to assess the correlation between sociodemographic factors (age, gender, race, 




abusers in Indiana.  The assessment of the correlation between health insurance status and 
successful treatment completion for opioid abuse was unexplored. The current study is 
going to fill the gap. In this chapter, I will discuss the search strategy regarding the 
sources of interest to develop a literature review and the theoretical 
foundation/conceptual framework on which the investigation was built on. 
Literature Search Strategy 
Numerous databases were searched to perform the literature review in this study. 
The search strategy included PubMed, Google, Google Scholar, EBSCO, Academic 
Search Premier, ProQuest, Allied Health Source, books, scholarly journals, and Medline. 
Some advanced searches have been applied from Walden University library to carry out 
the review. Also, published reports and articles from Federal and local governments 
websites such as CDC, the Indiana State Health and Marion County health departments, 
the National Institute on Drug Abuse (NIDA), as well as the Indiana University School of 
Public Health, the Department of Health and Human Services, and the World Health 
Organization websites were consulted.  
Phrases and search words used in this literature search strategy include 
sociodemographic factors, drug abuse, and factors contributing to drug abuse or 
addiction.  Also, the review has used wording such as mortality, morbidity, opioid abuse, 
opioid addiction, dependence, nonmedical substances, medical substances, licit 
substances, illicit substances, substance use, drug addiction, substance abuse, association, 
correlation, relationship, economic cost, health insurance coverage, treatment completion, 




meaningful articles used in this literature review (e.g., sociodemographic factors and 
opioid abuse, opioid, and D.P.H). This search strategy has enabled to retrieve relevant 
articles from 2004 to current. 
Given the scope of articles of interest, the researcher proceeds into the selection of 
these sources that meet the search criteria before placing any consideration. This enables 
the investigator to move with valuable information from relevant articles for more 
credible literature review. The criteria for inclusion in the search are opioid prescription 
abuse and sociodemographic factors. This enabled to retrieve only sources focusing on 
opioid abuse and its sociodemographic influences. The words opioid misuse, dependence, 
and addiction were avoided to prevent confusion in the search outcomes since the study 
was only concerned with opioid abuse. 
Theoretical Foundation 
The theoretical framework in this study will be based on SCT invented by 
Bandura in 1986. The SCT will be applied in the survey to help understand how personal 
behavior and socioenvironmental interact to influence health. SCT enables one’s 
behavior to be largely motivated and regulated by the persistent use of self-influence 
(Glanz et al., 2015). In Bandura’s complete description of SCT, human behavior is 
elucidated by three constructs such as behavior, personal cognitive, and 
socioenvironmental factors.  They all interact as reciprocal determinism (Glanz et al., 
2015).  
The use of SCT in health issues demands a clear understanding of reciprocal 




factors) (Glanz et al., 2015). Personal cognitive refers to the person’s aptitude to self-
direct, self-regulate, and evaluate contextual situations. Glanz et al. (2015) identified 
three constructs related to personal cognitive factors. Confidence to get involved in a 
certain behavior (self-efficacy) is one construct. The capacity of foreseeing the outcomes 
of behavior patterns (outcomes expectations) is another construct. Finally, there is the 
skill gained to enact a behavior (knowledge) [Glanz et al., 2015]. Socioenvironmental 
determinants refer to physical environmental aspects that promote, allow, or refusal to 
engage in a specific behavior. Socioenvironmental aspects involve observational 
learning, cultural beliefs to the acceptability of a given behavior (normative beliefs), 
social support, and the easing of health behaviors (opportunities and challenges) [Glanz 
et al., 2015]. Behavioral determinants or factors impact the health directly. Health 
behaviors involve health-enhancing actions that lead to people’s health improvement or 
poor actions leading to poor health (Glanz et al., 2015). Behavioral determinants involve 
the individuals’ health behavioral abilities (coping skills), their goals for behavior change 
(intentions), and the rewards for espousing a healthy behavior (reinforcement) [Glanz et 
al., 2015]. Glanz et al. (2015) noted SCT proposed that deterrence of mortality and 
morbidity via the increase of healthy behaviors and the lessening of unhealthy ones are 
accomplished through the change in these triadic factors (personal cognitive, 
socioenvironmental, and behavior) [Glanz et al., 2015].  
In SCT, goals are important in changing behavior. Bandura (2004) states that 
intentions are considered as goals since performing an action require individuals to 




When highly valued, goals have the potential to stimulate motivation towards adopting 
healthy behavior practices. Setting goals is one of the most appropriate steps in health 
behavior change.  
Social learning plays an essential factor in individuals’ substance abuse. This has 
been demonstrated by Tze et al. (2012) suggesting that students are educated to resist the 
drug abuse in a school-based prevention program, leading a substantial reduction of drug 
use among them. Tze et al. also noted school-based programs often apply the model 
because of the influences of social determinants on adolescents’ development and 
adolescents' susceptibility to higher risk behavior of substance abuse. The principle of the 
social-cognitive theory is that youths in substance abuse circumstances detect drug-using 
peers and start to observe and imitate drug use behaviors (Tze et al., 2012). Evidence 
revealed that when an adolescent observes a friend using drugs, he or she may change 
their beliefs and attitudes to using a drug (Tze et al., 2012). Similarly, non-drug users 
may experience drug use when engaging with individuals who use the drug. Tze et al. 
noted that when a group of close friends maintains a positive attitude toward substance 
abuse, non-drug users will be less willing to engage in drug use. However, other 
researchers refuted such correlation (Tze et al., 2012).  
Self-efficacy is another concept of SCT. It is a contextual assessment of a person 
confidence to perform a task. Besides, self-efficacy has a crucial role in individuals’ 
capability to be involved in high-risk behaviors (Tze et al., 2012).  According to social 
cognitive theory, individuals’ self-beliefs regarding substance abuse influences their 




has shown to affect their behaviors. That is, individuals’ self-efficacy to reject substance 
abuse are less likely to use drug. The higher the self-efficacy, the lower ability to engage 
in drug abuse (Tze et al., 2012). Therefore, self-efficacy has a protective effect on 
individuals drug use. 
Tze et al. (2012) noted that individuals’ self-efficacy of substance use plays a 
significant role in changing them towards drug-using behaviors. Tze et al. cited evidence 
from previous studies that showed a strong association between social learning and self-
efficacy.  It noted that when adolescents are exposed to free cocaine from friends and 
know how to inhale it, they will use it (Tze et al., 2012). That is, exposure to drug use by 
non-users can influence them and their substance use self-efficacy can rise just by 
observing others. 
Self-regulative mechanism functions through one’s self-monitoring behavior 
including its determinants and its effects. It is the use of one’s behavior that leads to the 
interactions between personal standards, environmental circumstances, and affective self-
reaction. Besides, self-regulation can embrace the self-efficacy mechanism, which 
promotes the use of personal entity through its effect on thought, motivation, and action 
(Glanz et al., 2015). This implies that drug abuse can be explained as behavior that is 
influenced by the user’s predisposed environment. Thus, personal determinants influence 
the behavior of the user. 
This SCT has been employed to many disorders, including the use of 
psychoactive substances. A study by Bennett et al. (2018) had applied the SCT model to 




in 2016. This cross-sectional research design by Bennett et al. (2018) reported that self-
control for taking medication for depression and expectations for taking medicine for 
depression were statistically significant with p<0.05. However, the researchers suggested 
that the integration of new models was necessary to bolster the SCT constructs (Bennett 
et al., 2018). Another study by Biro et al. (2017) used SCT to reduce stress in Hungarian 
college students. Expanding knowledge about psychoactive substances use to lessen 
stress and developing skills for stress reduction and management approaches are among 
the strategies used (Biro et al., 2017). 
The theoretical framework has proven to be useful in explaining behaviors related 
to drug use and understating personal actions for change. According to Glanz et al. 
(2015), SCT explains reasons for individuals to acquire and maintain healthy behaviors. 
It has also been used by researchers and practitioners to help them determine factors that 
stimulate health behaviors and to promote strategies for behavior change (Glanz et al., 
2015). For instance, da silva and Serra (2004) and Tze et al. (2012) applied the theory to 
understand factors that motivate drug use in individuals and promote preventive plans. 
However, Bandura’s SCT model has several limitations in the public health field. 
The theory assumes that changing environment leads systematically to changes in 
individuals, which is not always true (LaMorte, 2018). The theory seems loosely 
organized around personal, behavior, and environment, and does not clearly states 
whether one determinant has more influence on the others. The theory does not 
emphasize on motivation but rather on previous experience. Despite, Bandura’s SCT has 




In Giovazolias & Themeli (2014), researchers noted social cognitive theory self-
efficacy and outcome expectancies are two cognitive processes that influence a person’s 
behavior. Self-efficacy refers to the evaluation made by the individual relative to one’s 
ability to perform an action in a certain situation. And outcome expectancy refers to one’s 
beliefs that change in their behaviors may lead to desired outcomes or not (Giovazolias & 
Themeli, 2014). The outcome expectancies are acquired through direct experience of a 
certain behavior or via observation. Giovazolias & Themeli (2014) noted that the theory 
of social cognitive learning is used in substance use to assess outcome expectancies and 
have this theory for effective therapeutic interventions. 
Heydari et al. (2014) also examined the role of SCT in addiction quitting. 
According to the study, the purpose of addiction treatment is to help the client to admit 
addiction as a disorder and change in lifestyle can prevent the disease progress 
(Heydari et al., 2014). Heydari et al. (2014) found that using SCT can be effective in 
assisting individuals quit the addiction. 
I used the social cognitive theory (SCT) to help elucidate the outcomes of this 
quantitative research. The proposed framework has been widely employed to describe the 
mechanisms by which individuals learn about risky behaviors. Additionally, the model 
has been used in the initiation and the achievement of individual and group-level 
behavioral goals and has been effective in community health promotion strategies (Glanz 
et al., 2015). The SCT will be applied in this quantitative cross-sectional study to help 





The framework in this research is based on the philosophical worldviews for their 
influence in the research practice and need Creswell (2014). Four frameworks for 
research have been identified by Creswell (2014). This includes 
postpositivism/positivism, constructivism, transformative, and pragmatism (Creswell, 
2014). The term positivism refers to a set of scientific research practices, and the concept 
of knowledge, social reality, and of science (Riley, 2007). Positivism assumptions seem 
to represent the traditional form of research (Creswell, 2014). Positivism seems the most 
appropriate framework for this research. According to Creswell, positivism is seen as an 
approach for quantitative research. Positivism is related to various schools of thought, 
including empiricism, naturalism, behaviorism, scientism and determinism, and 
reductionism. It is reflected as a deterministic philosophy in which causes determine 
effects or outcomes (Shah & Al-Bargi, 2013). As a result, the issues investigated in this 
framework reflect the importance of identifying and assessing the origins (causes) that 
influence the outcomes (Creswell, 2014). This suggests that even though people may or 
may not know what causes them to abuse the drug, they would try to find out these 
causes and identify corrective actions.  
Based on the information described above, the Social Cognitive Theory (SCT) 
seemed the most appropriate in this quantitative cross-sectional study. The Theory 
focuses on the interaction between cognitive, behavioral, personal, and environmental 
factors to establish motivation and behavior (Weaver, 2016).  Glanz et al. (2015) noted 




behaviors. The model had also been used to attain individual and group-level behavioral 
changes (Glanz et al., 2015). SCT is an essential public health tool for promoting health 
and had been effective in managing addictive behavior such as tobacco and alcohol 
(Glanz et al., 2015). Similarly, SCT will be applied in this research to understand the 
sociodemographic factors, health insurance status associated with opioid abuse and 
treatment completion in Indiana residents to promote effective intervention plans. 
Literature Review 
Scope of Prescription Drug Abuse 
According to McCabe et al. (2017), medical and nonmedical use of prescription 
opioids has been a prominent problem nationwide for many decades. Other researchers 
revealed a sharp decline in the use of medical and nonmedical opioids (Kolodny et al., 
2015). The use of medical prescription opioids has demonstrated to be significantly 
associated with nonmedical use; Findings revealed that male adolescents have more 
likelihood to report both medical and nonmedical use of prescription opioids. Also, the 
study suggested that adolescents were more willing to initiate a medical prescription 
opioid before they initiated nonmedical prescription opioid (McCabe et al., 2017). The 
study by McCabe et al. (2017) noted that the increase in opioids prescription could have 
far-reaching opioid-related health consequences such as illegal use, opioid use disorders 
or addiction, high rate of emergency department visits, and overdose casualties. Also, a 
literature review by Bolshakova et al. (2018) noted that prescriptions of opioid had 
increased tremendously both nationally and globally in recent. While opioid can be used 




associated with increased risk of addiction, overdose, and significant psychological 
distress (Bolshakova et al., 2018). Similar trends were also found by Kolodny et al. 
(2015) and Oderda et al. (2015). 
The aim of McCabe et al. (2017) study was to investigate the trends of both 
medical and nonmedical use prescription opioids nationwide among high school seniors. 
The researchers used the Monitoring the Future (MTF) study for 135 schools to examined 
40 independent cohorts, applying random-sampling method. The MTF evaluates a host of 
behaviors, attitudes, and beliefs (McCabe et al., 2017). Among the major findings of the 
study, the Pearson correlation to assess medical and nonmedical use of prescription 
opioids (NUPO) demonstrated higher prevalence in black adolescents than whites’ 
adolescents with respectively (r = 0.79, P < .001) and (r = 0.65, P < .001). Earlier studies 
have revealed that female showed higher medical and NUPO use of prescription opioids, 
contradicting the findings of the current study (McCabe et al. 2017). One of the strengths 
of the study is that it highlighted the need for clinical opioid screening in adolescents to 
tackle the growing drug and mental disorders. A weakness of this cross-sectional study is 
self-reporting, which may lead to response distortion. I choose the article because it 
highlighted the role of both medical use and NUPO, which represent a damning concern 
for American society and for adolescents. The current study goes further to evaluate the 
association between sociodemographic factors, health insurance coverage and treatment 
completion for opioids abuse. 
Wisniewski et al. (2008) also assessed the correlations between medical opioid 




to explore the associations between prescription trends for hydrocodone, oxycodone, and 
morphine and indicators of nonmedical use and potential consequences in ED visits. 
Studies suggested that the trend of medical prescription of opioid analgesics has been 
increasing exponentially since the 1990s and that more hydrocodone combined with 
acetaminophen has been prescribed than any other drugs (Wisniewski et al., 2008). 
Researchers in this study noted that in 2004, about 2.4 million individuals12 years old 
and above have initiated nonmedical use of prescription of pain killer during last year, 
and evidence showed the use of such prescription drug was correlated with hydrocodone, 
codeine, propoxyphene, and oxycodone-containing products (Wisniewski et al., 2008). 
However, Meyer et al. (2014) reported a higher rate of 900%, 600%, and about 200% for 
methadone, oxycodone, and hydrocodone, respectively. Also, individuals using 
prescriptions of opioid analgesics have reached 79.5 million nationwide (Meyer et al., 
2014). 
Wisniewski et al. (2008) used a cross-sectional design to analyze four national 
databases including the National Hospital Ambulatory Medical Care Survey (NHAMCS), 
National Ambulatory Medical Care Survey (NAMCS), The Drug Abuse Warning 
Network (DAWN), and the National Survey on Drug Use and Health (NSDUH). 
Findings in the study found that medical use and nonmedical use of hydrocodone and 
oxycodone and ED visits were correlated and statistically significant yielding a p-value < 
0.04. Similarly, male sex, the White race, and age older than 35 were predictors of 
hydrocodone and oxycodone prescriptions with p-value < 0.0001 (Wisniewski et al., 




implications. The outcomes of the study highlighted the need for prescribers to pay close 
attention to opioid prescriptions because it may be diverted for nonmedical use. That is, 
physicians could limit or restrict opioid prescriptions to their patients to reduce 
prescription abuse. A weakness of this cross-sectional study was that secondary analysis 
does not establish cause and effect association by its nature. This article is relevant 
because of its focus on the relationship between opioid prescribing, nonmedical use, and 
emergency department visits. The current secondary data analysis will expand the 
knowledge and explore the association between health insurance coverage and treatment 
completion for opioids’ abusers. 
The United States has been experiencing for decades the problem of prescription 
opioid abuse and the underlining consequences of it, including overdose fatalities and 
substance abuse disorders continue to grow unabated. In the survey conducted by Han et 
al. (2017), researchers evaluated the prevalence of prescription opioid use, misuse, and 
use disorders and assessed motivations that lead to the abuse among U.S. adults. The 
survey suggested that nearly 91.8 million adults, accounting for 37.8% have used 
prescription opioids within the prior year. Among them, 11.5 million individuals (4.7%) 
abused them and 1.9 million (0.8%) developed substance use disorders (Han et al., 2017). 
Synthetic fentanyl is another form of deadly opioid that users are suddenly facing 
(Morales et al., 2019). Han et al. (2017) noted that the risks for abuse or misuse have 
complicated opioid prescriptions. The study used a cross-sectional design from the 2015 
National Survey on Drug Use and Health (NSDUH) to collect data. A large sample 




survey interview. Probability sampling methods have been applied in the study. Major 
findings of the survey revealed that among those who abused prescription opioid, 63.4% 
cited relief from physical pain as the reason while 47.8% of opioid use disorders cited 
pain relief as the main motivation. The conclusions of the research are consistent with 
earlier surveys (Han et al., 2017). 
Also, among participants who abused or misused prescription opioids, almost 2/3 
(59.9%) obtained them without a prescription at least once, and 40.8% got them from a 
relative (Han et al., 2017). However, a survey reported that 53% of prescription opioids 
for nonmedical use are easily accessible for friends or relative, 15% were bought from a 
friend, 21% prescribed by a physician, 3% prescribed by many doctors, 4.6 percent 
brought by drug dealer, less than 1% through internet purchased, and 4% via forgery 
(Tetrault & Butner, 2015). The findings may have practical implications since they 
highlighted the need for implementing policies that target medication sharing, selling, 
and diversion. However, the limitation of the study was that it reported a lower response 
rate, increasing the potential for nonresponse bias (Han et al., 2017). The article seemed 
relevant because it highlighted the significance of opioid prescription abuse, and it 
recognized the outcomes of such abuse (e.g., substance abuse disorders) while hinting for 
intervention strategies. Similar patterns had been reported by Bolshakova et al. (2019). 
Finally, a study by Strain et al. (2019) evaluated the epidemiology, pharmacology, signs, 
testing, and detection of opioid use disorder. Strain et al. (2019) noted that opioids are 
applied to treat medical conditions and to alleviate pain. Opioids may contain analgesic 




to opioid use disorder (OUD) which is linked to high morbidity and mortality (Strain et 
al., 2019). 
McHugh et al. (2014) noted that prescription drug abuse became a growing health 
issue in the nation. In this study, McHugh et al. (2014) aimed to explain a sampling of the 
recent  research related to prescription drug misuse or abuse ranging from its 
epidemiology, correlates, intervention outcomes, and from policy perspectives. The study 
suggested that between 1990 and 2000, nearly 3 million initiators of abuse in prescription 
occurred annually. The abuse in prescription drug has been increasing in recent years. 
McHugh et al. (2014) stated that opioids were the most frequently abused substance and 
had contributed substantially to the current crisis. 
McHugh et al. (2014) noted that the National Survey on Drug Use and Health 
believed that nearly 17 million individuals 12 years old and above had misused 
prescriptions nationally in 2012. About 2.1 million individuals align with the 
identification of a substance use disorder related to prescription drugs. Also, the number 
of adults who abused prescription of opioids went up from approximately 5 to 12.5 
million from 1992 to 2012. The paper noted that prescription of opioid use led the pack 
of drug abuse disorders, and ranked second after alcohol (McHugh et al., 2014). The 
study also noted that prescriptions of opioids abuse were correlated to a range of factors 
such as poor performance in school, violence, delinquent behavior, and psychological 
disorders (McHugh et al., 2014). The authors of this study used a collection of literature 
to review prescription of substance abuse from epidemiology standpoint to public policy 




prescription of drug abuse, most importantly, the prescription of opioid abuse and its 
health consequences and overdose fatalities in the United States. The study revealed 
further the need to improve training for prescribers, the prescription monitoring system, 
and accessibility to treatment centers (McHugh et al., 2014). One weakness of the study 
is that it does not elucidate the approaches used to collect data. The current cross-
sectional study will look further to assess the realtionship between health insurance 
coverage and treatment completion for opioids abuse to design policies to solve this 
growing public health problem. 
Prescription drug abuse (PDA) is not only emerging as a leading puclic health 
problem in the U.S.,  but also in Indiana. Oderda et al. (2015) noted that prescription drug 
abuse or PDA, particularly opioid abuse has been recognized as the fastest-growing threat 
to American society and has been classified as an epidemic according to the Centers for 
Disease Control and Prevention. This study noted that in 2013 alone, nearly 15.3 million 
people (about 6% of the population) reported using drugs for nonmedical reasons, citing 
pain relievers as the most common reason. Oderda et al. (2015) noted that between 
11,660,000 and 20,660,000 people used illicit drugs once in the year of 2009 (Oderda et 
al., 2015). The total prevalence of opioid dependence in North America has been 
estimated at 0.30% (Oderda et al., 2015). But, in Indiana, providers prescribed 74.2 
opioid prescriptions for every 100 persons in 2017 compared to 58.7 prescriptions across 
the United States (National Institute on Drug Abuse, 2019). In 2010, the rate was even 




Using a systematic review, the purpose of Oderda et al. (2015) was to analyze 
various data and summarize published evidence of the prevalence of prescription opioid 
abuse as well as its health consequences and societal costs. In this systematic review, a 
Population, Intervention, Comparator, Outcome, and Timeframe format or PICOT was 
applied and examined 5,281 citations. The study by Oderda et al. (2015) highlighted the 
significance of opioid abuse, the related costs, and health consequences.  The researchers 
in this review used appropriate approaches because the findings provided an overview of 
the prevalence of opioid prescription abuse, the costs, and health consequences. 
However, large missing data in the evaluation could impact the validity and reliability of 
the findings. If the data were completed, it might lead to different conclusions.  However, 
this current study will further explore the correlation between health insurance and 
treatment completion. 
Burden of Opioid Abuse 
Opioid prescription abuse and its overdose fatalities are becoming one of the 
major public health issues in the nation and particularly in Indiana. Previous studies 
found that approximately 1 million disability-adjusted life-years were attributed to opioid 
dependence (Gomes et al., 2018). In Gomes et al. (2018), the investigators also revealed 
that over half of the disability-adjusted life-years are due to years of life lost or YLL.  In 
a cross-sectional design study, Gomes et al. (2018) investigated the problem of opioid-
related mortality throughout the nation over time and had noted that prescription opioid 
overdose was responsible for 830, 652 YLL among individuals under 65 years old. The 




attributable to the recent use of fentanyl and other illicit opioids (Gomes et al., 2018). 
Florence et al. (2016) also noted that prescription opioids account for roughly 70% of 
drug overdoses fatalities. The survey by Gomes et al. (2018) applied the Centers for 
Disease Control and Prevention (CDC) WONDER Online Database to capture mortality 
and population estimates by age and gender. 
 Results from Gomes et al. (2018) indicated that 335, 123 people with opioid-
related mortality in the United States fit the standard selection and noticed a 345% 
increase from 33.3 deaths per million population in 2001 to 130.7 deaths per 1,000,000 
people in 2016. Males were the most vulnerable, accounting for 67.5% of all opioid-
related mortality, and having a median for age of 40. More alarming, the proportion of 
opioid death-related went up from1 in every 255 (0.8%) to 11 in 65 (1.5%) [Gomes et al., 
2018]. Nonetheless, the highest absolute increase was seen among individuals aged 25-34 
(from 4.2% in 2001 to 20% in 2016). Individuals aged 14-24 years were ranked second 
from 2.9% to 12.4%, respectively, in 2001 and 2016 (Gomes et al., 2018). The findings 
revealed that deaths related to opioids abuse accounted for 5.2 YLL per 1000 people in 
the United States for the year of 2016, with males being the most affected. Additionally, 
those aged 25 to 34 years and 35 to 44 years have the highest prevalence of opioid-
associated mortality accounting for 12.9 YLL per 1000 people and 9.9 YLL per 1000 
people, respectively (Gomes et al., 2018). These findings are significant because it calls 
for interventions targeting the most vulnerable population, as shown above. A limitation 
of the study was the definition used in the analysis, which impacts the validity of the 




deaths in the United States, showing opioid prescription abuse and its consequences to be 
one of the most pressing issues across the nation. The present study will expand further to 
assess the association between health insurance coverage and treatment completion for 
opioids abusers. 
Also, Kolodny et al. (2015) noted that high mortality rate had been associated 
with using opioid pain relievers or OPRs for alleviating pain, which has exacerbated the 
ongoing health epidemic. Earlier studies have reported that the prevalence of OPRs use 
nationwide has climbed over the last decade. According to the literature, the consumption 
of hydrocodone and oxycodone has jumped to 500% from 1999 to 2011. OPR-related 
overdose fatalities have reached four times high during the same period. The 
unprecedented public health issue has forced the Centers for Disease Control and 
Prevention to label it the “worst drug overdose epidemic in U.S history” and to list it 
among its top five public health priorities (Kolodny et al., 2015). The upsurge in opioid 
consumption has led to a sharp increase in ED room visits for nonmedical OPR abuse or 
misuse. 
Similarly, the rate of individuals seeking for OPRs addiction treatment rose to 
900%. Kolodny et al. (2015) noted that the association between opioid sales, opioid-
related overdose mortality, and opioid addiction treatment has been well-established. 
Also, the researchers reported that people who use OPRs switched to illicit opioid 
(heroin), and 94% of those reported doing so because it is cheaper to obtain and difficult 
for them to access OPRs. Moreover, the prevalence of opioid addiction has increased 




morbidity and mortality.  Kolodny et al. (2015) noted that Whites aged 20-34 were more 
likely to be admitted to rehabilitation centers for addiction treatment, while heroin 
overdose mortality for Whites aged 18-44 has climbed to 171%. 
In this article, Kolodny et al. (2015) aimed to describe the scope of OPRs use, the 
contributing risk factors and evaluate the role of addiction in aggravating the related 
mortality and morbidity. The strength of this study was that it recognized opioid 
dependence in medical and nonmedical users as the main driver of mortality and 
morbidity, contrary to the past where the focus has been made on medical users only. The 
weakness of the study is that the sample size and methods used to collect data were not 
described, which may affect its validity. This article seemed relevant because it focused 
on medical opioids as a public health concern and on its consequences (addiction and 
overdose mortality). However, it placed a special emphasis on heroin, aggravating the 
situation since it is cheaper to acquire by users. This study will expand knowledge by 
emphasizing on health insurance and relationship with treatment completion. 
Meyer et al. (2014) described the medical and financial burden of opioid 
prescription abuse or misuse by examining 183 articles from the National Ambulatory 
Medical Care Survey (NAMCS). The research aimed to conduct a comprehensive review 
of the literature to further understand the medical and financial burden of opioid 
prescription abuse. The authors noted that the use of nonmedical opioid pain killers has 
been surging and has become a pressing public health concern in the U.S. The article 
reported that between 2002 and 2007, the rate of nonmedical rose from 11 million 




of people misusing opiates other than illicit drug (heroin) had surged dramatically from 
1997 to 2007 with respectively 7 per 100,000 people to 36 per 100,000 people, 
accounting for 414% increase. The burden of opioid abuse has been growing, and Meyer 
et al. (2014) have estimated the opioid overdose-related mortality to range from 5,528 
deaths in 2002 to 14,800 deaths in 2008. Other published articles have shown higher 
figures recently. 
The article Meyer et al. (2014) also noted that the White House Budget Office 
estimated the medical expenditure for drug abuse to reach $300 billion annually. And in 
2007, the estimated costs for misusing opioid were predicted at $55.7 billion (Meyer et 
al., 2014). But the article by Florence et al. (2016) estimated the global financial burden 
for opioid abuse prescription and addiction at $78.5 billion. Meyer et al. (2014) found 
non-opioid pain killing substances stayed steady between 26%–29%, but the proportion 
of opioid prescriptions has jumped considerably from 11% in the year of 2000 to 20 % in 
2010. The outcomes showed that patients ‘prescription increases with age, accounting for 
11.7% for 10–29 years old and 45.7% for 40–59 years of age. A strength of the study is 
that it provides insights for clinical implications to target those most affected. A 
limitation is that investigators found it difficult to differentiate abuse from misuse and 
diversion, which may misguide policymakers in their decision. The current study will 
further assess the relationship between sociodemographic factors, health insurance 
coverage, and treatment completion. 
In a sudden twist of the situation, Morales et al. (2019) noted that fentanyl 




citizens. The article noted that drug abuse fatality in the United States reached a 
staggering number of 70,237 in 2017, accounting for 9% increase compared to the 
previous year. The paper noted that a new form of deadly opioid is now taking place, 
synthetic drugs such as illicitly manufactured fentanyl (IMF) and its equivalents. Morales 
et al. (2019) reported a sharp increase of IMF-related mortality from 3,105 in 2013 to 
20,145 deaths (649%) in 2016.  The article reported the distribution of IMF deaths in 
2016 in Baltimore (Maryland), Providence (Rhode Island), and Boston (Massachusetts) 
to be 80.6%, 32.5%, and 35.3%, respectively. 
This cross-sectional design by Morales et. (2019) used a sample of 308 
participants who have a history of heroin or opioid use within the last six (6) months. The 
outcomes of the study showed that willingness for using illegal nonmedical fentanyl have 
been reported in 27%. It found that people commencing opioid use without prescription 
opioid drugs have the likelihood to prefer fentanyl and 2/3 of the respondents reported an 
opioid overdose in the past year. The study found an association between fentanyl and 
sociodemographic factors like race and ethnicity (Morales et al., 2019). The findings of 
the study could provide clinical implication like screening for fentanyl presence. The 
limitation of the study is that it could be misleading because of social desirability bias. 
Ray et al. (2017) specifically examined opioid-related overdose trends in Indiana. 
The study assessed whether they are associated with variations in synthetic opioid 
medications. The authors used data from Marion County Coroner’s Office (MCCO), the 
Indiana Scheduled Prescription Electronic Collection and Tracking Program (INSPECT), 




Indianapolis Metropolitan Police Department (IMPD). The paper reported the prevalence 
of Indiana’s overdose fatalities to be 14.4 per 100,000 residents, ranking the state number 
17th nationwide (Ray et al., 2017). 
The toxicology test revealed that heroin, morphine, codeine, oxycodone, 
hydrocodone, oxymorphone, hydromorphone, and fentanyl were found to be the most 
common drugs used. Although hydrocodone and oxycodone remained the most 
prescribed opiates in Indiana, the study noted that heroin and fentanyl contributed mostly 
to the increase in overdose fatalities. But the National Institute on Drug Abuse reported 
that the age-adjusted rate of drug overdose has increased significantly in Indiana from 
2016 to 2017 with 24.0 deaths per 100,000 in 2016 to 29.4 deaths per 100,000 in 2017. 
Findings Ray et al. (2017) revealed that individuals aged 30-39 and 19-29 years 
old have the greatest mortality rate, with 26.6 % and 25.4%, respectively. The results also 
found a high proportion rate for male sex (66.7%), White ethnic group (85.3%), and 
never married or single (44.8%) [Ray et al., 2017]. A strength of this study is that it 
shows that Indiana State has fewer opioid treatment programs or OPTs (14) compared to 
other neighboring states like Illinois, Ohio, and Michigan. So, it provides insights for 
policy recommendations, including funding, and the creation of additional OPTs to avoid 
individuals from traveling a long distance to seek treatment. The study limitation was the 
researchers’ reliance on data, which may not be available sometimes as it has been the 
case for MCCO data. 
In another research by Lowder et al. (2018), the inquirers sought to demonstrate 




suggested that Indiana is ranked 17th nationwide when it comes to opioid fatalities. 
Opioid overdose mortality in the United States has been well-established. Despite that, a 
significant number remained unspecified (Lowder et al., 2018).  The study analyzed 
toxicology data in MCCO from 2011 to 2016 and examined a sample of 1,238 accidental 
poisoning deaths. 
The outcomes of the study revealed that 57.7% of accidental overdose deaths 
were undetermined and opioids played a role in 34.2%. The results of the investigation 
showed that 86.8% of the cases were confirmed positive for opioid. Further, findings 
showed opioid-related deaths has doubled from 32.4% to 86.0% (Lowder et al., 2018). 
Strikingly, the outcomes demonstrated that fentanyl-related overdose went from 5.4% in 
2011 to 51.5%, accounting for 853.7% increase (Lowder et al., 2018). However, 90% of 
the overall result involved opioid. Despite the massive spending by federal, state, and 
local government to curb the opioid epidemic, the failure to accurately evaluate fatal 
opioid-involved overdoses affects the effectiveness of the intervention strategies intended 
to address the issue (Lowder et al., 2018). One of the public health recommendations of 
the study was the improvement of local surveillance aiming at tackling the epidemic of 
opioid. As described by the previous survey, the reliance on population-level data to 
predict trends may lead to ecological fallacies (Lowder et al., 2018 and Ray et al., 2017). 
Many studies have focused on the relationship between sociodemographic factors 
and substance abuse (Lamptey (2005); Ranjan et al., 2010 and Simoni-Wastila & 
Strickler (2011)). Little is known about their association with successful treatment 




insurance coverage and successful treatment completion. This cross-sectional and 
secondary data analysis will expand knowledge by assessing the association between 
sociodemographic factors, health insurance coverage, and treatment completion outcomes 
for individuals abusing opioids. 
Sociodemographic Characteristics and Opioid Abuse 
The threat of substance abuse is a socially unacceptable truth, but it is also a 
disorder and has emerged as one of the top public health challenges of the new century. 
Globally, there is a growing trend in the number of individuals using substance abuse. 
This global issue of substance abuse has been influenced by social, economic, political, 
and psychosocial factors. The issue of drug abuse has contributed to rising tensions 
among societies (Rather et al., 2013). To understand this social phenomenon, Rather et al. 
(2013) investigates sociodemographic, and patients profile attending the drug 
rehabilitation unit.  
In the study by Rather et al. (2013), the authors conducted a descriptive study 
using the Drug De-addiction Centre (DDC) at the local Police Hospital of Srinagar. A 
total of 198 patients were interviewed (Rather et al., 2013). The study results found that 
for those who abuse the drug, the mean age was 26.8 years, and 56% of respondents 
belong to lower-middle class. Poly-substance abuse was noted in 91.9%, and that 
medicinal opioids and cannabis were the most widely used substances abuse. Also, 
76.8% of individuals started the initiation between 11 to 20 years old. Findings revealed 




study also noted the prevalence of a co-morbid psychiatric disorder to be high (Rather et 
al., 2013). 
The study by Ranjan et al. (2010) also reported that substances abuse is a global 
problem, but it recognized that societies used it for relieving pain and for pleasurable 
sensations. Using a cross-sectional design, Ranjan et al. (2010) examined 
sociodemographic factors that contribute to drug abuse among respondents aged 15 and 
above. Researchers applied a two-stage sampling method to collect data in Malvani 
location (India), and four areas were selected including MHB Colony (2728 houses), 
NCC Colony (12420 houses), Akashwani Area (5443 houses), and Ambujwadi (3000 
houses). Findings suggested that nearly 50 % tested positive for any single or multiple 
drug abuse habit. Participants aged 15-34 accounted for 59.8% of drug abusers. These 
outcomes were consistent with the previous study conducted by Gomes et al. (2018). For 
illiterate or primary or middle school levels, 72.1% of drug abusers were reported. The 
results also showed that 24.7% of drug abusers were illiterate compared to 16.9 % in 
nonabusers’ group. 53.1% represented the semiskilled workers, and 27.2% accounted for 
the unemployed group. 65.2% of men have initiated drug between the age of 15 and 24 
years old, and 81% of them cited peer pressure as the main factor. In their conclusion, 
Ranjan et al. (2010) noted that early age, illiteracy, low working status, and poverty are 
key drivers for drug abuse and that peer pressure plays a key role in the initiation stage 
for any drug abuse, especially for males. In their discussion, Ranjan et al. (2010) 
recommended training for parents and teachers by health professionals to curb this 




contributing to drug abuse. The present study will go further to investigate the association 
between health insurance coverage and treatment completion. 
Lamptey (2005) also investigated fifteen sociodemographic characteristics of 
abusers compared characteristics of non-substance abusers. Several studies demonstrated 
that drug abuse is a persistent issue among adolescents. Most of the substance abuse 
occurred between the mid-tens and mid-twenties (Gomes et al., 2018; Kolodny et al., 
2015; McHugh et al.,2014 and Wisniewski et al., 2008). Similar trends are shown in 
Lamptey (2005). According to Lamptey (2005), the age range of 15-24 years reported the 
greatest substance abuse, representing 83% of the population of the abusers. The study 
used a privately specialized clinic in Ghana to compared eighty-seven abusers to the 
same number of non-abusers. Findings revealed that substance abuse in adolescent males 
was statistically significant with p<0.05. Substantial variations between males and 
females regarding drug abuse were reported with p<0.05. The results found 1/3 of 
abusers abandoned their education early at the secondary level with p<0.05. Furthermore, 
results from Lamptey (2005) revealed that over half of abusers’ parents were divorced, 
separated, or never married. One final note was that the perception of parents ’attitudes 
and perception of siblings did not play a role in shaping responders’ way to abuse drug 
(Lamptey, 2005). Intervention plans targeting the above sociodemographic factors could 
ameliorate the rate of substance abuse and improve the overall health of the population. 
The article mentioned affordability as a limitation to the study because only those who 




factors related to opioids abuse, but the current research will further investigate the 
correlation between insurance coverage and successful treatment completion.  
In the survey by Simoni-Wastila & Strickler (2011), the researchers sought to 
approximate the frequency of prescription drugs problem and its associated risk factors. 
The survey applied data from the National Household Survey on Drug Abuse. A total of 
4,049 respondents were included in the survey. Variables such as race, age, gender, 
marital status, urbanicity, education, work status, health insurance, income, and general 
health status were considered in the survey.  Results found that 1.3 million individuals 
(15.5%) were considered as having an issue with a prescription drug. Having poor health, 
drinking alcohol, unmarried, having age of 35 and above, white race, and being female 
are predictors for prescription drug abuse. But full-time employment showed to have 
protective effects against the prescription drug problem. The strength of this study is that 
it was one of the first research emphasizing on the occurrence of issues related to 
prescription drugs and the underlying risk factors that are related to their use. This 
secondary data analysis will further explore the variables relationship with treatment 
completion for opioids abuse. 
Moreover, Swendsen et al. (2009) studied the prospective associations between 
sociodemographic variables and drug addiction using data from the National Comorbidity 
Survey (NCS) and the NCS Follow-up survey. Similar to previous studies, this survey 
noted that the health effects of drug dependence (disorders) has been classified among the 
global public health urgencies. Many studies have demonstrated strong correlations 




of drug disorders to be linked to gender, younger age, lower education, unmarried status, 
low income, and other variables reflecting disadvantaged social status. This is consistent 
with the findings of many investigations (Lamptey (2005); Ranjan et al., 2010 and 
Simoni-Wastila & Strickler., 2011). This survey used a total sample of 5,001 participants 
from the National Comorbidity Survey (NCS) and the NCS Follow-up survey aged 15-24 
years old, representing 87.6% baseline sample. Findings of the investigation revealed that 
many sociodemographic variables like in earlier studies are strongly correlated to drug 
addiction disorders like age, low education, ethnicity, and occupational. But, others like 
sex, residence, and number of children were not related (Swendsen et al., 2009). 
Swendsen et al. (2009) have practical recommendations targeting the most vulnerable 
populations. The study is significant for its emphasis on drug disorders and 
sociodemographic correlates. A strength of the study is its use of a large and nationally 
representative sample. The limitation of this survey is its assessment at baseline. This 
study will further explore the relationship between health insurance and treatment 
completion for opioids abuse. 
Farhat et al. (2015) discussed specifically opioid dependence. The aim of the 
survey was to find out whether the sociodemographic profile is linked to the trend of 
opioid-dependence in patients at a treatment center in India. The survey noted that 
dependence to opioids contributed to high morbidity and mortality and can result in a 
high prevalence of psychiatric illnesses. A cross-sectional design has been performed at 
addiction rehabilitation Centre of Institute of Mental Health and Neurosciences. A total 




American Psychiatric Association's Diagnostic and Statistical Manual of Mental 
Disorders (Farhat et al., 2015). The conclusions of the survey suggested that being young 
was associated with opioid abuse. Prescription diversion was the main reason for drug 
abuse, and peer pressure was highly correlated with initiating substance or drug abuse. 
However, self-motivation was the key driver for seeking treatment (Farhat et al., 2015). 
The study proposed a multidisciplinary collaboration or approach to tackle illegal and 
non-authorized use of prescription opioid and bring the issue of drug abuse under control. 
The limitation of the study was that it used a smaller sample, which has the potential of 
affecting the validity and reliability of the overall outcomes. 
Many cross-sectional studies have investigated sociodemographic factors with 
opioid abuse. A survey by Tavares et al. (2004) sampling 27,990 students aged 10-19 
years old, found a linear correlation between social class, age, and opioid abuse. Results 
also found being divorced, unemployed, and place of residence to be strongly correlated 
with drug abuse. In similar trend, Henkel (2011) found that unemployment was not only 
associated with drug abuse it can also augment the risk of relapse after drug addiction 
treatment. But the study found the religious belief to be protective against drug use. 
Another survey by Gul & Sharma (2017) examined sociodemographic factors and trends 
of drug abuse among subjects at a rehabilitation center using a sample of 300 participants 
averaging 29.8 years old. The results of the study found opioids abuse to be prevalent in 
179 (59.67%). Findings demonstrated that sociodemographic variables such as marital 
status (unmarried), low educational level, place of residence (rural), and low occupational 




are consistent with previous studies. The current investigation will learn more about the 
association between health insurance coverage and successful treatment completion. 
Research Involving Drug Treatment 
The opioid epidemic has become a public health crisis that affects people of all 
ages. Opioids are generally designed to relieve pain and can be very addictive. Licit 
substances (e.g., oxycodone, hydromorphone) and other illicit drugs like heroin are 
classified as opioids (Sanger et al., 2020). The use of opioid prescriptions can lead to 
opioids use disorder. Evidence suggested that in 2017, more than 2.1 million individuals 
suffered from an opioid use disorder because of prescription opioids abuse (Sanger et al., 
2020). Opioid misuse has been increasing since 2000, and an estimated 586,000 people 
have been affected by a substance use disorder in the United States (Maglione et al., 
2018). It has been reported that a high proportion of the population suffering from 
substance use disorder failed to enroll and receive adequate treatment services (Curtis, 
2013). Also, the refusal for substance abusers to undergo treatment can potentially, 
among others, increase the prevalence in mortality, lead to loss of income, alter an 
individual’s physical functioning, and bring up societal harm (Curtis, 2013). The need to 
treat substance disorder remains imperative, and a successful treatment completion can 
have positive outcomes and reduce treatment readmissions (Marie et al., 2015). 
Further, Turan &Yargic (2012) identified various factors that influence treatment 
completion, including individuals’ demographics, substance type and route of 
administration, the environment, and service settings or treatment program. But the 




individuals’ acceptance to seek treatment and their level of engagement to stay the course 
(Turan &Yargic, 2012). Furthermore, it had been revealed that the completion of 
treatment for substance use disorder produces meaningful outcomes than hasty retreat or 
withdrawal from treatment programs (Curtis, 2013). While there is a pressing need to 
address prescription opioid abuse and its underlying health consequences, the correlation 
between health insurance coverage and treatment completion outcome has often been 
explored. This study will examine the health insurance coverage for opioid users in 
Indiana and their correlated successful treatment completion. 
In a secondary data analysis, Marie et al. (2020) used the Treatment Episode 
Datasets-Discharge (TEDS-D) from the Substance Abuse and Mental Health Services 
Administration to examine the association between opioid admissions treatment referral 
source and successful treatment completions. The Treatment Episode Datasets-Discharge 
collects substance abuse data from funded public and private facilities in the United 
States and comprises about 1.5 million admissions annually (Marie et al., 2020). This 
study analyzed TEDS-D datasets from 2006-2010 using a large sample of N = 2,909,884 
population. This study used a chi-square test and Logistic regression for data analysis. 
Statistical analysis of the sample showed that healthcare professionals' referrals with 
lower successful treatment completion rates compared to other referral sources [OR = 
0.72, 95% CI 0.70 – 0.75; p < 0.0001]. Also, the results demonstrated that admissions for 
prescription opioids significantly lower treatment completion rates than other substances 
(Marie et al., 2020). These findings were significant because they might provide insight 




ongoing opioid crisis. Although the study assessed the correlation between treatment 
completion and referrals, it did not assess clients' health insurance coverage to see 
whether it plays a role in the treatment outcomes. This study intends to fill this gap. 
In another research, Turan & Yargic (2012) assessed the association between 
sociodemographic factors, substance use, and criminal activities on successful treatment 
completion. A total sample of 115 subjects aged 18 and older participated in the survey. 
Participants in this study were individuals for substance abuse treatment follow-up who 
were on probation at the Istanbul Probation and Help Center in Turkey. The study aimed 
to examine treatment completion rates on substance abuse among individuals on 
probation, substance use characteristics, and criminal activities (Turan & Yargic, 2012).  
This study's primary dependent variable was treatment completion, and the independent 
variables (predictors) consisted of sociodemographic factors, substance use types, and 
criminal history. Chi-square test, Fisher's exact test, and logistic regression were 
performed to analyze data. The study found the treatment completion rate to be at 59.1%, 
while non-completers represented 40.9%. The overall results demonstrated that 
sociodemographic factors were not statistically significant contrary to previous studies. 
However, the findings revealed statistical significance between substance use types and 
criminal activities on treatment completion (Turan & Tragic, 2012). The study might 
have practical ramifications in designing intervention strategies to tackle the problem of 
substance abuse and improve treatment outcomes. Nonetheless, the inclusion of small 
sample size, fewer females (only five of them took part in the study), and the selection of 




might affect the validity of the study. However, the study recommended further 
investigation be conducted that includes a larger sample with more females and 
adolescents for more meaningful outcomes. Overall, this study is significant because it 
explored the association between sociodemographic factors, substance use types, and 
treatment completion on substance abusers. The current secondary data analysis will 
explore further the impact of health insurance coverage on treatment completers. 
Moreover, the study by Sanger et al. (2020) investigated the correlation between 
the source of first opioid exposure and treatment outcomes. The authors used a systematic 
review and meta-analysis to carry out their investigation. The database searches used 
included EMBASE, MEDLINE, PsycINFO, and CINAHL (Sanger et al., 2020). During 
the analysis, 27,345 articles had been examined; the investigators utilized five 
observational studies in their mixed-method analysis (qualitative and quantitative). The 
findings of this investigation revealed that individuals who were initially exposed to 
opioids via prescription had less likelihood of using illegal opioids while undergoing 
medication-assisted treatment than those exposed to recreational drugs. This systematic 
review analysis found that initial exposure to opioids via prescription or recreational 
means can impact treatment outcomes for opioid addiction (Sanger et al., 2020). Findings 
revealed that no significant relationship was found in treatment length between 
prescription opioid and recreational use initiation. The study suggested that increase 
prescription of opioids can contribute to a high prevalence of opioid use disorder. 
However, the implementation of a new approach can improve OUD's treatment outcomes 




investigators to employ screening approaches that involve all studies. However, one of 
the study's limitations was the lack of adjusting for confounding variables, which might 
affect the validity of the outcomes. Another limitation was that only data from North 
America and Australia were analyzed, which might affect the generalization of the 
outcomes. This study seemed significant because it raised the public health concern of 
opioid prescription and its contribution to opioid use disorder while focusing on their 
influence related to treatment outcomes. The current secondary data analysis will look 
further to assess sociodemographic factors and the impact of health insurance on 
treatment completion rates. 
Treatment for opioid addiction is important to improve the well-being of those 
affected. It has been well-documented that access to medications for opioid use disorder 
in residential addiction treatment facilities can be effective in individuals with such a 
problem (Huhn et al., 2020). Despite substance abuse treatment availability, many 
challenges still exist, including accessibility and lack of insurance coverage, among many 
others (Huhn et al., 2020). In a study conducted by Huhn et al. (2020), the investigators 
assessed the accessibility and application of MOUDs in residential addiction treatment 
facilities. The purpose of the study was to investigate whether there are differences 
between access to MOUDs and their use in residential treatment facilities. It also assessed 
the relationship between facility-level with access to MOUD and admissions-level. The 
inquirers applied a cross-sectional study design by examining large data surveys from the 
2017 National Survey of Substance Abuse Treatment Services, 2017 Treatment Episode 




coverage (Huhn et al., 2020). Descriptive statistics and logistic regression were 
performed in this analysis. Findings revealed that individuals who were admitted for 
treatment were predominantly men (67 %%), White patients (74%), and those aged 25-54 
(81%). The study results showed that only 1.3% of treatment facilities offered all 
MOUDs to those affected, and 60% did not. Also, residential facilities offering XR-NTX 
generated greater odds of offering both buprenorphine and methadone with [OR, 22.93; 
95% CI, 17.95-29.28; P < .001] and [OR, 6.73; 95% CI, 3.33-13.62; P < .001], 
respectively. Most importantly, the study results suggested that individuals with opioid 
use disorder and seek treatment at residential facilities where the care was expected to be 
of quality failed to receive the care they needed (Huhn et al., 2020). One limitation was 
that facilities reporting for individuals receiving MOUDs might not be known, which 
might affect the study's generalizability. Overall, the study and its conclusions seemed 
significant. It called for the need to address the ongoing problem of the opioid epidemic 
in the United States while restricting access to those who need it. There is an existing 
belief that most patients do not access quality care because of a lack of health insurance 
coverage. The current secondary data analysis proposes investigating further and whether 
there is an association between health insurance and treatment completion for opioid 
users. 
A survey by Brown (2010) examined predictors of substance abuse treatment 
completion in drug court. The survey's measured demographic profiles, socioeconomics, 
substance use, and criminal justice background of participants. The number of subjects 




performed to assess such associations (Brown, 2010). Bivariate logistic regression 
revealed that being unemployed, belonging to the non-whites race, and having the highest 
grade completed were among predictors of substance abuse treatment completion. 
Multivariate regression was performed and demonstrated that unemployment, lower 
educational attainment, and cocaine were correlated with failure to complete treatment. 
Similar outcomes were found by Knight et al. (2001). However, the use of administrative 
data and self-reporting were considered limitations of the study (Brown, 2010). However, 
Newton-Howes & Stanley (2015) rebutted the findings and found that primary, 
secondary, high school, and college levels compared to graduate-level were predictive of 
a greater likelihood of treatment completion. This study seemed significant to the current 
research because it assessed demographic factors that predict failure to substance abuse 
treatment. 
Besides, Suntai et al. (2020) examined racial differences related to substance use 
treatment completion among older adults using a cross-sectional design. The study aimed 
to ascertain the extent of racial discrepancies regarding substance use treatment 
completion among older adults. The study analyzed the Treatment Episode Data from the 
Substance Abuse and Mental Health Services Administration (Suntai et al., 2020). Chi-
square tests, bivariate, and multivariate logistic regression were utilized to analyze the 
data. Findings showed that Blacks were less likely to complete a substance use treatment 
program than Whites with OR = 0.630. Also, males were more likely to complete 
treatment than females with OR = 1.288. There no difference found in marital status. But 




those employed with OR = 0.799. Similar trends were found in the survey conducted by 
(Bazargan-Hejazi et al., 2016). This survey was meaningful because it assessed treatment 
completion predictors in outpatient, residential facilities and utilized a cross-sectional and 
secondary data analysis to report their findings. 
Nonetheless, Guerrero et al. (2014) investigated gender discrepancies related to 
substance abuse treatment service use and outcomes within racial and ethnic groups. The 
survey used a prospective longitudinal design from the National Treatment Improvement 
Evaluation Study (NTIES) longitudinal in the United States. Descriptive statistics, chi-
square, and analysis of variance were performed in this study. The study's findings 
revealed that women from all subgroups benefited from services and treatment outcomes 
compared to men (Guerrero et al., 2014). Besides, the study found that gender as a 
moderator in the analysis. However, it found that females were more likely to enter 
residential treatment facilities. There was no statistical difference between gender and 
treatment completion with (OR: 0.93, 95% CI: 0.86–1.00) [Bazargan-Hejazi et al., 2016]. 
Another survey also found no gender differences in substance abuse treatment (Brown, 
2010). The current study will assess similar demographic characteristics and their 
association with treatment completion outcomes. 
A study by Stahler & Mennis (2020) also examined to see if medications for 
opioids use disorder (MOUD) can lead to treatment completion and retention in short-
term and long-term residential programs. The study used large datasets from the 2015–
2017 TEDS-D (Treatment Episode Dataset-Discharge) for opioid using adults in 




multiple logistic regressions were applied to carry out the analysis. Findings of the study 
showed that in short-term residential treatment, MOUD was associated with a greater 
likelihood of treatment completion (OR = 1.404) and increased retention rate (OR = 
1.337) [Stahler & Mennis, 2020]. However, in long-term residential treatment programs, 
MOUD was less likely to complete treatment (OR = 0.743) and found no difference in 
retention (Stahler & Mennis, 2020). The significance of this study was that it evaluated 
predictors for short-term and long-term residential treatment completion and retention, 
part of the purpose of the current. However, it failed to report the association between 
participants' sociodemographic characteristics and short-term and long-term residential 
treatment completion and retention outcomes. 
Health Insurance Coverage and Substance Abuse Treatment 
Opioid abuse has been affecting Americans from every age group. Studies 
suggested that many individuals have died from opioid abuse or opioid-related substance. 
In 2018, the CDC reported three quarters (70%) of total deaths in the United States 
attributed to opioids (CDC, 2020). Data revealed that licit prescriptions of opioids and 
street opioids play a significant role in this skyrocketing death rate. The good news is that 
treatment exists in tackling substance abuse in general and, specifically, opioids abuse. 
Huhn et al. (2020) recommended that the residential treatment facility setting seemed to 
be the most effective treatment-level for dealing with this public health issue. However, 
many barriers might impede the successful completion of treatment, including health 
insurance coverage and access to services utilization. Implementing evidence-based 




morbidity due to substance abuse (Feder et al., 2019). It had been shown that only 10% of 
those affected by substance use disorder could access treatment (Feder et al., 2019). The 
reason for that was the lack of health insurance coverage that refrained people from 
seeking treatment for opioid use disorder. People with low socioeconomic status were 
more vulnerable. The relationship of health insurance coverage with opioid abuse and 
access to treatment services has often been explored, and this study intended to do so. 
In the article by Feder et al. (2019), the researchers sought to understand the 
impact of health insurance on individuals using injectable drugs. Using the AIDS Linked 
to the Intravenous Experience (ALIVE) data, the investigators extracted a sample size of 
1724 adult participants who reside across the Baltimore area in Maryland. Among 
variables assessed by the researchers included dependent variables (Receipt of specialty 
substance use treatment, Receipt of buprenorphine, and having a usual source of medical 
care) and the independent or predictor variable of self-reported health insurance status 
(Feder et al., 2019). Data were analyzed using descriptive statistics and logistic 
regression models. The results showed the participants' mean age to be 51, and 30 percent 
of them were HIV tested positive. Also, males have a higher frequency of visits (2/3), 
while 90% of participants were African Americans. The most striking outcomes exhibited 
a statistically significant correlation between insurance type use and treatment receive 
with z = 2.7 and p < .01. Findings revealed that having health insurance coverage had 





Furthermore, it showed that having insurance was strongly correlated with higher 
medical care use (Feder et al., 2019). Finally, it demonstrated that holding health 
insurance can be associated with the use of specialty substance use treatment (OR 2.0, 
95% CI 1.6 to 2.5). The findings were significant because it might enable to design 
interventions that expand health insurance to those uninsured. However, the study had 
some limitations. The study was able to assess only treatment to buprenorphine. But the 
study had not assessed Methadone and Naltrexone treatments and their association with 
having insurance. Also, the study could not control for all confounding factors, and the 
sample size was predominantly African American, which might affect the 
generalizability of the outcomes. The current secondary data analysis will assess whether 
acquiring health insurance predicts treatment completion outcomes for opioid users. 
Another article by Cummings et al. (2014) discussed private health insurance 
coverage and specialty treatment admissions for substance abuse disorder. The survey 
aimed to assess the association between private health insurance and the receipt of 
treatment for specialty substance use disorder. The study compared the receipt of 
specialty for substance abuse treatment between uninsured and individuals having private 
insurance. Data from the National Survey of Drug Use and Health or NSDUH using a 
cross-sectional design. A large sample of 177,462 people aged 18 to 64 participated in the 
survey (Cummings et al., 2014). Among the variables of interest assessed were receipt of 
specialty treatment for substance abuse (inpatients and outpatients) from rehabilitation 
centers (dependent variable) and health insurance coverage on categorical level 




including gender, marital status, age, race/ethnicity, employment status, income level 
(Cummings et al., 2014). Findings revealed that private insurance was significantly 
correlated with the increased use of any specialty substance use disorder care for 
individuals experiencing alcohol addiction with a p-value <0.05 (Cummings et al., 2014). 
Logistic regressions were performed to establish an association between the dependent 
and independent variables. Cummings et al. (2014) further reported that cost and lack of 
health insurance coverage were among the main problems’ individuals face for substance 
abuse treatment. In another survey regarding the lack of insurance coverage in workers, 
the outcomes demonstrated that uninsured workers have a higher likelihood of using 
alcohol and other illicit drugs than those who were insured. It further showed uninsured 
workers lacked drug assistance programs known as EPAs by employers than insured 
workers (Miller et la., 2007). However, Cummings et al. (2014) suggested that the recent 
enactment of the Mental Health Parity and Addiction Equity Act (MHPAEA) in 2008 and 
the Affordable Care Act (ACA) of 2010 were both designed to expand health insurance 
coverage for substance use disorders to improve treatment outcomes. Although 
Cummings et al. (2014) did not say whether an association existed between the selected 
sociodemographic profiles, a survey by Allcock et al. (2019) found a marked correlation 
between health insurance coverage and gender, education, and income. The current study 
will expand further in assessing such association. 
A study by Mojtabai et al. (2020) investigated private health insurance use with 
substance disorder treatment. In contrast with Cummings et al. (2014) findings, the 




having coverage was statistically significantly associated with receiving treatment with 
[OR = 2.09, 95% CI = 1.61–2.72, p < .001]. Also, the results from Mojtabai et al. (2020) 
found that participants with coverage were older than those lacking coverage (60.8% vs. 
43.7%). Those with having coverage tend to be more educated than those without 
coverage (58.7% vs. 50.4% had any college education, p < .001) and gained significant 
family income than those without coverage (77.7% vs. 61.6%) [Mojtabai et al., 2020]. 
Further, Allcock et al. (2019) assessed sociodemographic patterns associated with health 
insurance in Namibia using a large sample of 14,443 aged 15 to 64 years. The survey 
applied multivariable mixed-effects Poisson regression analyses. The results of the study 
by Allcock et al. (2019) demonstrated that health insurance was associated with health 
service utilization and was independently associated with sex, education, and wealth. 
These findings were significant. The current study will further investigate the association 
between sociodemographic factors and treatment completion for opioids abusers and the 
association between health insurance and treatment completion. 
Another study by Olfson et al. (2018) assessed variations in private insurance 
coverage and behavioral treatment for individuals aged 19 to 35 years after implementing 
the Affordable Care Act on provisions of insurance coverage. The researchers applied a 
cross-sectional design and extracted from the 2008 to 2016 National Surveys on Drug 
Use and Health (NSDUH). The survey measured Health insurance coverage type and 
treatment for substance use disorders. Additionally, the survey assessed 
sociodemographic variables, including income, marital status, student status, and 




mental health issues by applying the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) [Olfson et al., 2018). Findings of the survey 
revealed a significantly more significant increase in private insurance for individuals 
aged 19 to 25 years compared to 26 to 35 years with (7.7 % points; P < .001) and (1.2 % 
points; P = .02), respectively (Olfson et al., 2018). Also, the study results found among 
patients with selected substance use disorders, there was a significantly greater coverage 
increase for individuals aged 18 to 25 years than for 26 to 35 years (9.0% points; 95% CI 
= 5.5%, 12.5%). It found that the younger age group with substance use disorders had 
significant gains in coverage (Olfson et al., 2018). 
Treatment Options for Opioid Abuse 
Despite the devastating health consequences of opioids abuse, there are various 
treatments available for opioid dependence or abuse (Stotts et al., 2009). However, 
Cummings et al. (2014) suggested that many individuals with substance abuse or drug 
problems cannot access care because of lack of health insurance and the high costs of 
service provided. Stotts et al. (2009) identified two ways for treating opioids dependence, 
including opioid maintenance treatment and detoxification, and in many cases, patients 
utilize both. The most recommended medications for opioid addiction include agonists, 
partial agonists, and antagonists (Stotts et al., 2009). Agonist and partial agonist 
medications are administered for maintenance and detoxification. The antagonist is used 
to enhance outcomes (Stotts et al., 2009). The most common agonist medication used for 




for opioid dependence. Naltrexone is administered as an opioid dependence antagonist 
(Stotts et al., 2009). 
-Methadone: Methadone is used for replacement therapy for heroin and other 
opiates dependence.  A dose ranging from 80 – 150 mg is recommended with 20-30 mg 
starting daily dose. The dose is increased by 5 or 10 mg gradually until the maximum 
dose is attained (Stotts et al., 2009). Methadone maintenance treatment or MMT has 
shown to be effective in improving treatment retention and outcomes and lowering 
mortality rates (Stotts et al., 2009).  However, there is growing evidence that Methadone 
can increase relapse for opioid dependence (Stotts et al., 2009). The use of methadone is 
known to be correlated with cardiac effects (Stotts et al., 2009). 
-Buprenorphine: Is used as a partial agonist to control opioid withdrawal 
symptoms. The recommended oral for Buprenorphine oral is 24 or 32 mg. Partial agonist 
use has decreased the risk of overdose and improved treatment retention outcomes (Stotts 
et al., 2009). But Stotts et al. (2009) suggested that partial agonist might have the ability 
to reduce Buprenorphine optimal efficacy. 
-Naltrexone: Naltrexone is administered orally and is known as a long-acting 
opioid antagonist that has proven effective for preventing relapse of alcohol and opioid 
dependence (Stotts et al., 2009). Fifty (50) mg of naltrexone is recommended. Higher 
doses of naltrexone are sometimes administered for a longer duration of action (Stotts et 
al., 2009). However, patients who use naltrexone can experience some side effects such 




These literatures were selected because they assessed key variables in this analysis 
(independent and dependent variables). 
Existing Policies for Opioid Abuse  
Many public health initiatives have been implemented to tackle the growing 
problems of higher prevalence of opioid prescription misuse nationwide and across local 
jurisdictions. In 2006, CDC had undertaken robust efforts to track better and understand 
data related to the opioid overdose epidemic. In that optic, CDC has crafted five (5) 
strategies designed to prevent opioid abuse, overdose, and deaths. Monitoring cases of 
abuse using surveillance and research, involving tribal leaders, local and State 
jurisdictions, providers, and payers are among the initiatives. CDC also was committed to 
empowering consumers to make choices and to partner with public safety (CDC, 2019). 
Many studies have also proposed and implemented treatment and preventive measures 
related to opioid abuse. Treatment measures such as the creation of de-addiction centers 
have been used to help those who are suffering from opioid use disorder (Farhat et al., 
2015; Heydari et al., 2014 and Tetrault and Butner ., 2015). Other studies focused on 
education-based interventions to help them abandon opioid prescription abuse (Morales 
et al., 2019; Tetrault and Butner (2015); and Tze et al., 2012). 
One of the important initiatives implemented in Indiana State to curb the opioid 
crisis is the NextLevel Recovery Indiana. The initiative focuses on prevention, treatment, 
enforcement, and training for healthcare professionals. The NextLevel Recovery Indiana 
provides access to resources, emergency personnel, community leaders, and supports to 




Health, 2019). Indiana state applies the Indiana Scheduled Prescription Electronic 
Collection and Tracking (INSPECT) surveillance system to track down and address 
prescription drug abuse and diversion (ISDH, n.d). 
Summary  
The prevalence of prescription drug abuse increased significantly and faster in 
recent years in the United States. Opioids remained the most widely abused prescription 
drugs and show to contribute to the worsening of the epidemic. Many studies and 
literature reviews recognized opioid abuse as the most pressing challenge in the public 
health field. They also demonstrated the need to address such a growing public health 
problem.  Several studies showed that opioid abuse led to high mortality and morbidity 
rate (Gomes et al., 2018; Meyers et al., 2014; and Morales et al., 2019). 
Various studies investigated sociodemographic factors with opioid abuse. 
Findings from these studies demonstrated a marked association between 
sociodemographic profiles and prescription opioid abuse. The outcomes noted that 
sociodemographic factors like race, sex, single, younger age, residence, and 
unemployment are strongly correlated with prescription drug abuse (Lamptey (2005); 
Ranjan et al., 2010 and Simoni-Wastila & Strickler (2011)). But other studies found few 
sociodemographic factors were not related to opioid abuse. Nevertheless, the association 
between sociodemographic factors for opioid abuse and their relationship with treatment 
completion had been assessed. It had been shown that sociodemographic factors are 
significantly correlated to opioid abuse treatment completion. But other studies disputed 




types and specialty treatment for substance use disorder, more specifically with alcohol, 
and found that individuals with coverage have better access to treatment. Others disputed 
such a claim. The implementation of recent regulations in 2008 and 2010, such as 
MHPAEA of the ACA, respectively by congress, has led to the expansion of coverage for 
substance use disorder.  The current quantitative cross-sectional research will further 
assess the association between sociodemographic attributes, health insurance coverage, 
and treatment completion for opioids abuse in Indiana. Despite high expenditure for 
substance use and opioid abuse, but the crisis continues to grow. This literature review 
offered the necessary tool for the research method (chapter 3), which incorporates the 
research questions and the design format to carry out this study. The research method 
section will discuss the recruitment of subjects, sampling method used, collection of data, 




Chapter 3: Research Method 
Introduction 
This cross-sectional and quantitative research design sought to investigate the 
association between sociodemographic factors and treatment completion for opioid 
abusers in Indiana. The study also sought to examine the association between health 
insurance coverage and treatment completion for opioid abusers in Indiana. The 
completion of this study will provide another perspective for improving the treatment and 
retention for opioid abusers in Indiana, including for individuals having a problem 
accessing care because of a lack of health coverage. Further, the outcomes of this study 
would help expand insurance coverage and improve access to care. This cross-sectional 
and quantitative research was guided by the questions below: 
1. Is there any association between sociodemographic factors and treatment 
completion for opioid abusers among residents in Indiana?  
2. Is there any association between health insurance coverage and treatment 
completion for opioid abusers in Indiana?  
3. Is there any association between health insurance coverage and treatment 
completion for opioid abusers in Indiana after controlling for sociodemographic factors? 
This chapter will discuss the study’s research design and its rationale and the 
detailed research methodology, including the population study, sample size, sampling 
procedures, and data collection. Besides, the chapter will describe the instrumentation 
and operationalization, the data analysis plan, and threats to validity of the study. Finally, 




Research Design and Rationale 
I will use the 2017 Treatment Episode Data Set Discharges (TEDS-D) from the 
Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of 
the U.S. Department of Health and Human Services. A quantitative cross-sectional study 
design was applied. The data used were deidentified and were publicly accessible. 
Indiana data were extracted from the datasets for this analysis. This study sought to 
evaluate the association between sociodemographic factors, substance abuse (opioid only 
reported at admission), and treatment completion for opioid abusers. Besides, the extent 
of the relationship with treatment completion will be assessed when controlling for the 
selected sociodemographic factors. There is limited literature on health insurance 
coverage on treatment completion. This study will fill the gap by examining the 
association between health insurance coverage for treatment and successful treatment 
completion for opioid abusers at discharge. 
Dependent and Independent Variables 
The primary dependent variable (DV) considered in this study was successful 
treatment completion status at discharge. Treatment completion in this dataset was 
defined as “all parts of treatment plan or program were completed” (TEDS-D, 2017). 
This secondary data analysis will apply this definition concept. The outcome variable of 
treatment completion was measured on a categorical level. Therefore, the researcher used 
the variable successful treatment completion as “Treatment completed” or “Treatment not 
completed” for any reasons such as “dropped out of treatment, terminated by the facility, 




Another outcome variable involved in this research was opioid abuse (opiates/synthetics 
abuse) for individuals using opioids as their primary substance use. 
The independent variables (IV) in this study included sociodemographic attributes 
(education, gender, age, race, marital status, and employment) and health insurance 
coverage at admission. The independent variables predict or forecast the values of the 
dependent variable in the model (Statistics Solutions, 2019). In a research study, the 
independent variable is tested to determine its relationship regarding an observed 
phenomenon (Siegle, n.d).The selected sociodemographic attributes were measured as 
categorical. Opiates/synthetics represented the substance reported at admission. 
Opiates/synthetics were considered in this study as any substance use containing opioid 
and drug morphine-like effects that individuals reported at admissions as their primary 
substance use (TEDS-D, 2017). It included buprenorphine, codeine, hydrocodone, 
hydrocodone, hydromorphine, meperidine, morphine, opium, oxycodone, pentazocine, 
tramadol) [TEDS-D, 2017]. In this study, opiates/synthetics were measured as a 
categorical variable. Finally, health insurance coverage was measured as dichotomous 
(insured versus uninsured). 
The research method best suited was cross-sectional and quantitative research 
design. The rationale for choosing a cross-sectional study approach allows evaluating 
whether there is a correlation between exposures (IV) and outcomes (DV) variables at 
one time (Setia, 2016). Another justification for this study was the availability and 




is the most convenient for public health planning, monitoring, and evaluation (Setia, 
2016).  
This study examined the correlation between sociodemographic factors (education 
status, gender, age, race, marital status, and employment status) and opioid abusers in 
Indiana. Additionally, the current research analyzed the association between health 
insurance coverage at admission and treatment completion status for opioid abusers in 
Indiana. The analysis of data was performed using SPSS. The researcher will run 
descriptive statistics to display data summary. Also, Chi-square and logistic regression 
were performed. The outcomes would enable identifying specific sociodemographic 
attributes and health insurance coverage that predict successful treatment completion 
status for opioid abusers in Indiana. Understanding these factors could help promote 
positive social change by implementing policies that expand health insurance coverage 
and improve treatment outcomes for opioids abuse in Indiana. This may improve 
morbidity and mortality rates related to opioid abuse and overdoses in Indiana. 
Much research had been conducted to explore sociodemographic factors with 
opioids abuse but limited research on the association between health insurance coverage 
and successful treatment completion. This research was intended to fill that gap. 
Understanding the relationship between health insurance coverage and successful 
completion of opioid abuse treatment is essential in the public health field. There is a 
common belief that substance abusers having a government type of insurance or not 




 When completed, this study could design policies to expand health insurance 
coverage for individuals dealing with substance abuse problems at the state and local 
levels. Investigating the association between the selected sociodemographic factors, 
health insurance coverage, and treatment completion for opioid abusers may help 
promote positive social change. The study could help expand insurance coverage for 
substance abusers, including opioid abusers and underserved individuals. This study's 
findings would improve treatment outcomes and reduce morbidity and mortality due to 
opioid abuse among Indiana residents.   
Methodology 
Population 
Background of Indiana population characteristics 
The state of Indiana is in the Midwest region of the United States. It is one of the 
largest and most populated states ranking 38th and 17th, respectively. Indianapolis is the 
capital and the largest city in the state. There are 92 counties in Indiana, and Marion 
County, where Indianapolis seats, is the largest and most populated counties in Indiana. 
According to the United States Census Bureau (2019), the population of Indiana was 
estimated at 6,732,219 residents as of 2019. The racial distribution of the population 
includes Whites (84.8%), Blacks (9.9%), Latinos (7.3%), Asians (3%), and the rest 
represent Native Americans (U.S. Census Bureau, 2019). The population is composed of 
50.7% females and 49.3% males. The percentage of individuals earning high school 
degrees or higher is 88.6% and those with a bachelor’s or higher represents 25.9% (U.S. 




individuals were estimated at 3,275,056 while unemployed represented 112,310, and the 
state unemployment rate stands at 3.3% (U.S. Census Bureau, 2018). The mean age was 
estimated at 37.9. 
The 2019 U.S. Census Bureau reported the preschool population in Indiana aged 0 
to 4 to be 418,340. This number represents 6.2 percent of the general population 
estimates. The school-age (5 to 17 years old) was 1,149,634 people, accounting for 17.1 
percent. Estimates showed the population of individuals having college-age (between 18 
and 24 years old) to be 659,745. This figure represents 9.8 percent of the total population. 
Additionally, younger adults aged 25-44 account for 1,719,646 people, representing 25.5 
% of the general population (U.S. Census Bureau, 2018). Furthermore, the same data 
revealed the population of older adults between 45 and 64 years old to be 
1,699,111people, accounting for 25.2 percent of Marion County population. Finally, the 
population of individuals aged 65 and more was estimated at 1,085,743 people (16.1%) 
[U.S. Census Bureau, 2018]. The above age distribution of the population showed 
individuals aged 25-44 to be the greatest (25.5%), followed by older adults or 45-64 (23.7 
%), school-age (17.1%), older people (16.1%), College-age (9.8%), and preschool (6.2%) 
[U.S. Census Bureau, 2018.] Knowing these demographic characteristics of Indiana is of 
paramount importance for undertaking this cross-sectional design study.  
Target Population 
I used the 2017 TEDS-D dataset to conduct this analysis. The Treatment Episode 
Data Set Discharges or TEDS-D represents annual discharges from substance abuse 




discharges but report admissions to accredited treatment facilities for substance abuse 
that receive local and federal funding. TEDS-D recorded information for individuals aged 
12 and older (TEDS-D, 2017).  
The current cross-sectional, quantitative research approach was applied to address 
the severe problem of opioid abuse and overdoses that Indiana faced. McLeod (2014) 
defined a target population as the entire group of subjects or individuals to which 
investigators are interested in generalizing the outcomes. The target population involves 
specific characteristics and is the group from which the sample may be drawn (McLeod, 
2014). Evidence suggested that opioid abuse in the U.S affected younger people aged 24-
45 more than any other age group (Gomes et al., 2018). The attributable opioid-related 
mortality was highest among adults aged 25-34- and 35-44-years. A similar trend was 
seen in Indiana, and data showed that individuals aged 18 to 25 years old were more 
vulnerable than other groups (NIDA, 2018). It had been shown that individuals aged 18 
and older are predominantly the most affected by opioid abuse in Indiana and this cross-
sectional study was going to focus on this age group. It was expected to see the target 
population to reach many thousand in Indiana. 
Sampling and Sampling Procedures 
Sampling Strategy 
The present cross-sectional study sought to evaluate the relationship between 
some sociodemographic attributes and successful treatment completion for opioid abusers 
in Indiana. Sociodemographic factors were adjusted to evaluation their relationship with 




insurance coverage and treatment completion for opioid abusers in Indiana. A simple 
random sampling strategy was applied in this cross-sectional study. This type of sampling 
seemed the most appropriate because of its tendency to use a probabilistic approach 
where subjects have an equal chance of being selected, and the drawn sample is more 
representative of the target population (Elfil & Negida, 2017). 
Inclusion of participants comprised of the selected sociodemographic 
characteristics (age, gender, race, education, employment status, and marital status), 
opioids abuse reported at admissions as primary substance (other opiates/synthetic 
abuse), completion of treatment at discharge, health insurance status, and being 18 and 
older. Exclusion criteria included participants less than 18 years and all missing cases 
following the missing at random (MAR) procedure. I used any precautionary measures to 
ensure accuracy of data being analyzed.  
Sampling Procedures 
The sample size for this cross-sectional design study was determined by using the 
power calculator, G*Power 3.1.9.7. The use of G*Power in this research helps to 
determine an a priori practical compromise sample size. G*Power is a stand-alone, very 
useful power analysis program for conducting various statistical assessments that are 
frequently used in the social, behavioral, and biomedical sciences (Faul et al., 2009). For 
the determination of sample size, it is essential to apply statistical power, which can help 
the researcher to avoid type I and type II errors (Faul et al., 2009).  
In this analysis, the parameters for calculating sample size were set on Z-Tests 




as the statistical test to be conducted. In addition, the medium effect size was set to be a 
choice because setting the “a priori” effect size level that is too high or too low has the 
potential of increasing the risk for error (Sullivan, 2012). Setting the effect size is 
indispensable because, as stated by Sullivan (2012), it is the main finding of a 
quantitative study. Further, a p-value can tell the reader about the real effect, but the p-
value cannot estimate the effect (Sullivan, 2012). We set an acceptable coefficient of 
determination (effect size), also known as R square to be 0, representing a measure of the 
proportion of variance between the variables and can vary from 0 to 1. Using the 
G*Power with a confidence interval of 5 % and considering a power of 0.95, the 
generated sample size for achieving empirical validity with two or more predictors was 
estimated to be 988 participants. However, to ensure greater power, I used the entire 
sample contained in Indiana datasets. 
Table 1 
 
Protocol of Power Analysis 
z tests - Logistic Regression 
Options: Large sample z-Test, Demidenko (2007) with var corr 
Analysis: A priori: Compute required sample size  
Input: Tail(s) = One 
 Odds ratio = 1.3 
 Pr(Y=1|X=1) H0 = 0.2 
 α err prob = 0.05 
 Power (1-β err prob) = 0.95 
 R² other X = 0 
 X distribution = Normal 
 X parm μ = 0 
 X parm σ = 1 
Output: Critical z = 1.6448536 
 Total sample size = 988 




Z Tests: Protocol of power analysis for the determination of sample size and interactions  
Analysis: A priori: Compute required sample size 
Figure 1 
 
G* Power Analysis for the Required Sample 
 
Data Collection 
Participants can be accessed through the 2017 TEDS-D archival data managed by 
the Substance Abuse Mental Health Services Administration (SAMHSA). TEDS-D data 
gathered information on individuals’ demographics, their substance abuse pattern, and 
their admissions and treatment outcomes at discharges from all facilities receiving public 
funds. The data collected in the 2017-TEDS-D concerned individuals aged 12 and older, 




composed of two major components, including admissions and discharges (SAMHSA, 
2019). 
Indiana data was extracted from the TEDS-D datasets, and participants in this 
study were individuals who reported abusing opioids as their primary substance use. The 
information gathered to be examined would include participants’ sociodemographics 
(age, gender, race, educational level, employment status, and marital status), health 
insurance coverage status, reported opioid abuse at admissions and completed treatment 
at discharge. However, we estimated the sample size to be 988 participants using 
G*Power tools. The population of individuals undergoing substance abuse treatment in 
Indiana was estimated to be 21,000 people (SAMHSA, 2019).The collected data in the 
TEDS-D were publicly available and de-identified. The material contained in the TEDS-
D document is presented in the public domain and does not require permission to be 
accessible (SAMHSA, 2019). Data were accessible on Substance Abuse and Mental 
Health Data Archive (SAMHDA) through CDC WONDER. Because TEDS-D was the 
most trusted data sources for substance abuse and mental health, it is generally accepted 
as reliable. 
Instrumentation and Operationalization 
Instrumentation 
The survey instrument tool applied in this cross-sectional study to collect 
information from participants was the Treatment Episode Data Set – Discharges (TEDS-
D) of 2017. Reported data concerned all U.S. facilities receiving public funds for 




Admissions components involved individuals’ demographic characteristics, primary, 
secondary substance use, secondary substance use, tertiary substance use, route of 
administration, frequency of use, age at first use, and source of referral to treatment 
(SAMHSA, 2019). Besides, it included a number of prior treatment episodes and service 
types. While discharges information included the type of service at discharge, length of 
stay, and reason for discharge (SAMHSA, 2019). Only three states were excluded in 
TEDS-D 2017, including Georgia, Oregon, and West Virginia, for lack of sufficient data 
reporting (SAMHSA, 2019). 
Operationalization 
The researcher used the 2017 TEDS-D codebook in the definition of the variables 
of interest. 
Age: Using TEDS-D of 2017, the variable was used as the date of birth of the 
patient at admission (SAMHSA, 2019). The variable was measured as categorical and 
recorded into a different variable named Age_Group with four categories. The new 
recoded age variable comprises of five subcategories, including 1= “18-34”, 2= “35-44”, 
3= “45-54”, and 4= “55 and older”. Individuals aged less than 18 were excluded. 
Education: The education variable was described in the TEDS-D as the highest 
level of school years completed by subjects (SAMHSA, 2019). The variable has six 
subcategories but was recoded into four subcategories, including [1=Primary (<8 years), 
2=Secondary (9-11years), 3=High School (12years), 4=College (13-15years), 





Employment status: This variable specifies the subject’s employment status at the 
time of admission and has four subcategories (SAMHSA, 2019). It includes “Full-time, 
Part-time, Unemployed, Not in the labor force” (SAMHSA, 2019). The variable was 
measured as categorical in this study. 
Race: Is “a multidimensional social construct and is considered as a predictor of 
exposure to external health risks posed by environmental, social, and behavioral factors” 
(Ford & Kelly, 2005). In the United States, race is defined as “White, Blacks or African 
American, Asian, American Indians and Alaska Native, Native Hawaiian and Other 
Pacific Islander, or other (U.S. Census Bureau, 2019). The researcher applied the defined 
variable in the 2017-TEDS-D. Race was recoded and considered in analysis as 1= Native 
Americans (Alaskans, American Indians, Pacific Islanders), 2=Blacks, 3=Whites, and 
4=All others (other single and two or more races). The variable was measured as 
categorical. Latinos group was not listed in the TEDS-D survey. 
Gender: Is defined as a social construct, representing biological and physiological 
differences between both sexes (female and male) (WHO, 2020). The variable of gender 
designates the subject’s biological sex (Male and female), as described in the 2017-TEDS 
(SAMHSA, 2019). It was measured on the categorical level (1=Male and 2=Female). 
Marital status: Refers to subject conjugal condition. This variable is termed in the 
TEDS-D ‘‘Never married,’’ ‘Now married,” “Separated,” and “Divorced, widowed’’ 





Health insurance coverage: Designates the subject of health insurance status at 
the time of admission (SAMHSA, 2019). The variable was measured as categorical and 
encompassed various labels, including “Private insurance, Blue Cross Shield, HMO,” 
“Medicaid,” “Medicare, other,” “None.” In this analysis, the variable was recoded into 
HLTHINS_Group by combining “Private insurance” and “Government insurance” into 
one category (1=Insured), and “None” (not having insurance coverage) was recoded into 
another category 0=Uninsured. 
Reason for discharges or discontinuance of treatment: “Indicates the outcome of 
treatment or the reason for transfer or discontinuance of treatment” (SAMHSA, 2019). 
The variable was used as categorical and had several subcategories, including “Treatment 
completed,” “Dropped out of treatment,” “Terminated by the facility,” “Transferred to 
another treatment program or facility,” “Incarcerated,” “Death,” and “Other” (SAMHSA, 
2019). In this analysis, the variable was recoded into Reason_Group to form two 
categories (1=Treatment completed and 0=Treatment not completed). 
Opioid abuse: signifies other opiates/synthetics reported at admission by subjects 
as their primary substance use, including buprenorphine, codeine, hydrocodone, 
hydromorphone, meperidine, morphine, opium, oxycodone, pentazocine, propoxyphene, 
tramadol, and any drug having morphine-like effects (SAMHSA, 2019). This variable 
was measured as categorical. The variable stayed intact, as described in the codebook. It 
has two subcategories, including 1= “substance reported” at admissions) and 0= 




Data Analysis Plan 
The data collected analysis involved the use of the Statistical Package for the 
Social Sciences, version 25(SPSS). Indiana sub-data was extracted from the TEDS-D. All 
missing data were eliminated following the missing at random (MAR) procedures to 
ensure accuracy of the data. The independent or predictors variables considered in this 
analysis were sociodemographic factors (age, gender, race, education, employment status, 
and marital status) and health insurance status. The two independent variables were 
measured as categorical. Whereas the dependent or outcome variables were identified as 
binary. Opioid abuse (opiates/synthetics abuse) was defined as “Substance abuse not 
reported” vs. “Substance abuse reported." The outcome variable treatment completion 
was defined as “Treatment not completed” vs. “Treatment completed." This study's 
research questions were answered, and hypotheses tested using statistical analyses such 
as descriptive statistics, chi-square, and logistic regression. 
Research Question 1: Is there any association between sociodemographic factors 
and treatment completion for opioid abusers among residents in Indiana? 
H01: There is no association between sociodemographic factors and treatment 
completion for opioid abusers among residents in Indiana. 
Ha1: There is an association between sociodemographic factors and treatment 
completion for opioid abusers among residents in Indiana. 
RQ2: Is there any association between health insurance coverage and treatment 




H02: There is no association between health insurance coverage and 
treatment completion for opioid abusers in Indiana 
Ha2: There is an association between health insurance coverage and 
treatment completion for opioid abusers in Indiana 
RQ3: Is there any association between health insurance coverage and treatment 
completion for opioid abusers in Indiana after controlling for sociodemographic factors? 
H03: There is no association between health insurance coverage and 
treatment completion for opioid abusers in Indiana after controlling for demographic 
factors. 
Ha3: There is an association between health insurance coverage and 
treatment completion for opioid abusers in Indiana after controlling for sociodemographic 
factors. 
It is essential to point out that descriptive statistics do not lead to conclusions 
regarding any hypotheses that might have been formulated (Laerd Statistics, 2018). 
Ultimately, descriptive statistics are just a way to describe the data analyzed. This makes 
descriptive statistics more critical when analyzing data because of their ability to allow a 
simpler interpretation of the data (Laerd Statistics, 2018). This can be done by presenting 
the results in tables or graphs. The statistical test Chi-square is generally known for 
testing correlations between categorical variables. In this analysis, the chi-square test's 
null hypothesis considers that no relationship exists on the population's independent 
categorical variables (Statistics Solutions, 2019). The Chi-square statistic is displayed as 




appropriate choice to analyze when the dependent variable is dichotomous (Statistics 
Solutions, 2020). Logistic regression is applied in describing data and clarifying the 
association between one dependent binary variable and one or more variables (Statistics 
Solutions, 2020). The expected results in this analysis will be presented in the form of 
odds ratio (OR), confidence interval (CI), and p-value. 
For Research Question 1 (RQ1): 
Descriptive statistics were conducted to display data summary for 
sociodemographic characteristics (age, race, gender, education, employment status, and 
marital status). Preliminary chi-square tests and multivariate logistic regression between 
sociodemographic attributes and opioid abuse (opiates/synthetics abuse) were performed 
to evaluate their association. Besides, basic chi-square tests and multivariate logistic 
regression were conducted to assess the relationship between sociodemographic factors 
and treatment completion outcomes. 
For Research Question 2 (RQ2): 
Descriptive statistics were carried out to display health insurance coverage and 
the outcome variable of treatment completion. The researcher used chi-square tests and 
bivariate logistic regression to evaluate the relationship between health insurance 
coverage and treatment completion. 
For Research Question 3 (RQ3) 
A multivariate logistic regression was run to assess the association between health 
insurance and treatment completion after adjusting for sociodemographic factors (age, 




Threats to Validity 
It has been demonstrated that the main threats to the reliability and validity of 
secondary data analysis evolve from the accuracy of the approaches used during the 
primary collection of such data (Boo & Froelicher, 2013). Issues may come from survey 
sampling, data collection, non-response, and missing data. The investigator did not 
participate in the initial research design and data collection; it is imperative to 
comprehend the accuracy of the dataset being investigated (Boo & Froelicher, 2013).  
In this study, there might be potential threats to reliability and validity. SAMHSA 
reported that an external factor, such as funding availability, could threaten the validity of 
this study (SAMHSA, 2019). Evidence suggested that states with higher funding tend to 
admit many substance-using individuals for treatment (SAMHSA, 2019). 
On the other hand, funding constraints may lead states to limit their ability to 
admit a larger number of substance abusers; hence, it enabled them to target only special 
populations in their areas (SAMHSA, 2019). Another threat that might influence the 
results was that several states considered many admissions for the same patient, meaning 
data represent admissions only instead of the client (SAMHSA, 2019). Thus, data might 
contain several entries for one client. This might potentially affect the reliability and 
validity of the study. Also, non-response and missing information in the national survey 
might influence the validity of the overall results. 
However, the extracted data from Indiana, which was examined in this study, 
seemed accurate. The data contained a large sample and an insignificant number of 




substance abuse and mental health. Researchers are urged to access and utilize SAMHSA 
data repository files for public health purposes (SAMHSA, 2019). Therefore, TEDS data 
files are accurate and trustworthy. In analyzing the data, the researcher used statistical 
regression and randomization to overcome potential validity threats. Nonetheless, all 
missing data from the extracted Indiana sub-dataset were eliminated using the MAR 
process. Therefore, the statistical data analysis yielded accurate and precise results from 
the study. 
Ethical Procedures 
Researching human subjects can lead to ethical challenges. Public health ethics 
deal with recognizing, analyzing, and resolving ethical issues derived from public health 
practice and research (Coughlin, 2006). Ethical challenges in public health are usually 
linked to the necessity of public health professionals to obtain and use scientific 
knowledge to protect the public's general health while respecting the rights of individuals 
(Coughlin, 2006). Emphasizing ethical issues when conducting human subjects’ research 
can facilitate effective planning, implementation, and improvement of public health plans 
and research (Coughlin, 2006). 
The present secondary data analysis study examined data from 2017 Treatment 
Episode Data Set Discharges. The datasets were retrieved from Substance Abuse and 
Mental Health Data Archive (SAMHDA), and Indiana subdatasets will be extracted. The 
datasets were publicly available and can be accessed 
at: https://www.datafiles.samhsa.gov/ dy-dataset/teds-d-2017-ds0001-teds-d-2017-




initially collected, the researcher understood that a consent form was given to 
participants, and the results will be used for future research. Therefore, participants’ 
confidentiality in this data analysis would not be affected.  
Prior to analyzing the datasets in this study, the proposal was submitted to the 
Walden Institutional Review Boards for review. Approval would be granted to the 
investigator or researcher before the start of data analysis to ensure research compliance 
with the university's ethical standards as well as U.S. federal regulations. Information 
about opioid abuse subjects, including their demographics, substance use, health 
insurance, and treatment completion status, were accessible from the public domain 
through SAMHDA. In this secondary data, the information being treated would be 
protected under pass-worded computer. There was no conflict of interest involved in the 
process of this research, the dataset was publicly available. 
Summary 
Substance abuse is a growing socio-medical problem. The researcher applied a 
quantitative cross-sectional design by extracting Indiana from the 2017 TEDS-D datasets. 
The study analyzed the association between sociodemographic factors (age, gender, race, 
employment, education, marital status) and treatment completion status for opioid abuse 
in Indiana. Further, it assessed the association between health insurance coverage and 
treatment completion. A simple random sampling strategy to draw a representative 
sample was applied because of its ability to offer subjects an equal chance of being 
selected. Included in this data analysis were individuals aged 18 and older. G*Power 




population of Indiana. The investigator performed various statistical tests, including 
descriptive statistics, chi-square, and multivariate logistic regression, using IBM SPSS 
version 25. This cross-sectional study's overall results will help promote positive social 
change in Indiana by designing and implementing policies to reduce the opioid abuse 





Chapter 4: Results 
Introduction 
In this study, I examined the association between sociodemographic factors (i.e., 
age, gender, race, marital status, employment status, and education level) and successful 
treatment completion outcomes among opioid abusers in Indiana aged 18 years and older. 
The present study also sought to investigate the association between health insurance 
coverage and treatment completion outcomes for opioids abusers in Indiana among 
individuals aged 18 years and older. I formulated the following research questions along 
with subsequent hypotheses to conduct this study: 
RQ1: Is there any association between sociodemographic factors and treatment 
completion for opioid abusers among residents in Indiana? 
H01: There is no association between sociodemographic factors and treatment 
completion for opioid abusers among residents in Indiana. 
Ha1: There is an association between sociodemographic factors and treatment 
completion for opioid abusers among residents in Indiana. 
RQ2: Is there any association between health insurance coverage and treatment 
completion for opioid abusers in Indiana? 
H02: There is no association between health insurance coverage and 
treatment completion for opioid abusers in Indiana.  
Ha2: There is an association between health insurance coverage and 




RQ3: Is there any association between health insurance coverage and treatment 
completion for opioid abusers in Indiana after controlling for sociodemographic factors? 
H03: There is no association between health insurance coverage and 
treatment completion for opioid abusers in Indiana after controlling for sociodemographic 
factors. 
Ha3: There is no association between health insurance coverage and 
treatment completion for opioid abusers in Indiana after controlling for sociodemographic 
factors. 
In this analysis, the investigator adjusted sociodemographic factors to evaluate the 
association between health insurance coverage and treatment completion outcomes after 
adjusting the potential confounding effects of age, gender, race, employment, education, 
and marital status using multivariate logistic regression. Overall, chapter 4 will discuss 
data collection process used and the results of the data analysis of the study.   
Data Collection 
This research used TEDS-D archival data from SAMHSA, a national collection of 
annual discharges from substance use treatment services in 2017. TEDS-D represents 
admissions to licensed or certified facilities by state agencies for substance use treatment 
services; those facilities are mainly sponsored by states or drug agencies (SAMHSA, 
2019).  The TEDS-D is a nationally representative sample, although it does not include 
all substance use treatment facilities in the United States. The data were de-identified and 




approval from Walden University Internal Review Board (IRB).  The researcher IRB 
approval on November 17th, 2020, and the approval number was 11-17-20-0721940. 
Within two days after the IRB approval, I accessed the SAMHSA website, and 
TEDS datasets were transferred on SPSS and stored in a password-protected USB key for 
analysis. The researcher then extracted Indiana state (#18 in the codebook) data from the 
national survey and analyzed the variables of interest. It included sociodemographic 
attributes (i.e., age, gender, race, employment status, education level, and marital status); 
health insurance coverage status; reported opioid abuse at admissions and completed 
treatment at discharge. We expected the baseline for education, marital status, 
employment status, gender, race, age, and health insurance coverage to be high school 
level, single, full-timers, female, whites, age group 18-34 years, and insured, 
respectively.  
There was a total of 21,611cases generated for Indiana from the TEDS-D datasets, 
which represented 1.3% of the total cases in the national survey. After the Indiana 
datasets were analyzed and missing cases were removed, the number dropped to 20,822 
cases. Following the inclusion and exclusion criteria, the analytic sample used in this 
study was set to be 20,822. Using SPSS, descriptive statistics, preliminary chi-square 
were applied. Additionally, bivariate and multivariate logistic regression analyses were 
the main statistical tests used and the results were reported in odds ratio. The dependent 
variables were treatment completion and opioid abusers.  The independent variables were 




status, gender, race, and age. The outcomes and independent variables were defined and 
measured as follow: 
Table 2 
 
Variables and Coding 
Variable Coding 





Gender (IV) 1= “Male” 
2= “Female” 
 
Race (IV) 1= “Native Americans” 
2= “Blacks or African Americans” 
3= “All Others” 
4= “Whites” 
 
Education (IV) 1= “Primary” (<8 years) 
2= “Secondary” (9-11years) 
3= “College” (13-15years) 
4= “Graduate” (16 and more) 
5= “High School” (12years) 
 
Marital status (IV) 1= “Divorced, widowed’’ 
2= “Separated” 
3= “Now married” 
4= “Never married’’ 
 





Health insurance coverage (IV) 0= “Uninsured” 
1= “Insured” 
 
Opioid abuse (DV) 0= “substance not reported” 
1= “substance reported”  
 
Treatment completion (DV) 0= “Treatment not completed” 







Research Question 1 
Descriptive statistics for association sociodemographic factors and opioids 
abusers 
I performed descriptive statistics for sociodemographic factors, opioid abuse 
(Other opiates/synthetics reported at admission), and treatment completion outcomes 
(reason to group). The respondents' sociodemographic characteristics included age, 
gender, race, education, employment status, and marital status.  Data were summarized in 
table 3, including frequency distribution and a percentage per category of each variable. 
Males represented 59.9 % of the sample, while females made up 40.1 %. The sample was 
made up of 49.1 % of high school level, followed by secondary (24.0%), college (20.3%), 
primary (3.8%), and graduate (2.8%). Among respondents, 63.1 % represented "Never 
married", followed by "Divorced, widowed" (21.5%), "now married" (14.1 %), and 
"Separated" (1.4%). The sample was made up of 40.7% of unemployed, 31.6 % of full-
time workers, 16.3% of individuals not in the labor force, and 11.3% of part-time 
workers. Regarding the age group frequency distribution, the sample comprised of 18-34 
(52.1%), 35-44 (25.0%), 45-54 (17.2%), and 55 and older (5.7%). There were more 
whites recorded in the sample accounting for 80.8%, Blacks or African Americans 
(13.9%), All Others (0.4%), and Native Americans (4.9%). Among participants, 19.9 % 
reported abusing opioids, while 80.1% did not report abusing opioids. Finally, 29.7% of 






Descriptive statistics demographic characteristics of sample 
Variable Category Frequency (N) Percent (%) 



























Employment Status (IV) Full-time 
Part-time 
Unemployed 
























18-34   
35-44  
45-54 

















Treatment completion status 
(DV) 









Chi-square results for association between sociodemographic factors and 
opioid abusers  
Chi-square was conducted to assess whether sociodemographic factors were 
associated with opioids abusers. The results from Chi-square for the association between 




gender, race, and age) and opioids abusers were statistically significant for all of them 
yielding a p-value < 0.05, with the effect size varying from small to medium. 
The results from the analysis exhibited statistical significance between education 
and opioids abusers with [Pearson χ2(4, N = 20822) = 18.028, p = 0.001, Cramer’s V= 
0.029] (see tables 4 and table 5). Findings between marital status and opioids abusers 
were statistically significant with [Pearson χ2 (3, N = 20822) = 38.540, p = 0.001, 
Cramer’s V= 0.043] (see table 6 and 7). Besides, the association for employment status 
revealed significance with [Pearson χ2 (3, N = 20822) = 51.717, p = 0.001, Cramer’s V= 
0.050] (see table 8 and 9). Also, gender showed significance with [Pearson χ2 (1, 
N=20822) =142.480, p=0.001, Cramer’s V=0.083] (see table 10 and 11).  Furthermore, 
the association with race yielded statistical significance too with [Pearson χ2 (3, N = 
20822) = 492.672, p = 0.001, Cramer’s V= 0.154] (see table 12 and 13). Finally, it 
demonstrated the relationship between age and opioids abuse was significant with 




Chi-square results education vs. opioids abusers 
                                          Value                       df        Asymptotic Significance (2-sided) 
Pearson Chi-Square 18.028a 4 0.001 
Likelihood Ratio 18.245 4 0.001 
Linear-by-Linear 
Association 
435 1 0.510 






Effect size for association education and opioids abusers 
  Value Approximate 
Significance 
Nominal by Nominal   Phi 0.029 0.001 
 Cramer’s V 
 
0.029 0.001 




Chi-square for association marital status vs. opioids abusers 
                                         Value                  df                 Asymptotic Significance (2-sided) 
Pearson Chi-Square 38.540a 3 0.000 
Likelihood Ratio 38.092 3 0.000 
Linear-by-Linear 
Association 
24.908 1 0.000 




Effect size for association marital status and opioids abuser 
                                                             Value                          Approximate Significance 
Nominal by Nominal       Phi 










Chi-square for association between employment status and opioids abusers 
                                          Value                            df                Asymptotic Significance (2-sided) 
Pearson Chi-Square 51.717a 3 0.000 
Likelihood Ratio 51.846 3 0.000 
Linear-by-Linear 
Association 
31.059 1 0.000 






Effect size for association marital status and opioids abusers 
                                                            Value                          Approximate Significance 
Nominal by Nominal           Phi 










Chi-square for association between gender and opioids abusers 
 
 







Pearson Chi-Square 142.480a 1 0.000   
Continuity Correction b 142.058 1 0.000   
Likelihood Ratio 140.663 1 0.000   
Fisher’s Exact Test    0.000 0.000 
Linear-by-Linear 
Association  
142.473 1 0.000   




Effect size for association between gender and opioids abusers 
                                                                  Value                          Approximate Significance 
Nominal by Nominal           Phi 












Chi-square for association between race and opioids abusers 
                                          Value                     df                Asymptotic Significance  
Pearson Chi-Square 492.672a 3 0.000 
Likelihood Ratio 616.124 3 0.000 
Linear-by-Linear 
Association 
235.528 1 0.000 




Effect size for association between race and opioids abusers 
                                                             Value                          Approximate Significance 
Nominal by Nominal           Phi 




   0.000 
0.000 




Chi-square for association between age and opioids abusers 
                                          Value                  df               Asymptotic Significance  
Pearson Chi-Square 318.205a 3 0.000 
Likelihood Ratio 350.593 3 0.000 
Linear-by-Linear 
Association 
301.720 1 0.000 






Effect size for association age and opioids abusers 
                                                              Value                      Approximate Significance 
Nominal by Nominal           Phi 






N of Valid Cases 20822  
 
Multivariate logistic regression for association between sociodemographic 
factors and opioids abusers 
The researcher performed a multivariate logistic regression analysis to examine if 
age, gender, race, education, marital status, and employment status predicted opioid 
abuse (other opiates/synthetics). Recall that other opiates/synthetic comprised 
buprenorphine, codeine, hydrocodone, hydromorphone, meperidine, morphine, opium, 
oxycodone, pentazocine, propoxyphene, tramadol, and any other drug having morphine-
like effects). In this analysis, the dependent variable of interest was opioid abuse (other 
opiates/ synthetics). The predictor variables included education, marital status, 
employment status, gender, race, and age. In this logistic regression model in table 16, 
the reference groups for education, marital status, employment status, gender, race, and 
age were high school, never married, full-time, female, whites, and age group 18-34, 
respectively. 
Education level: In the multivariate logistic regression (table 16), high school 
educational level was used as the reference category.  It was expected that having low 
educational is more likely to abuse drug (Gul & Sharma, 2017).The results demonstrated 




demonstrated that compared to high school level, secondary level was 1.2 times more 
likely[OR=1.189, 95% CI (1.088, 1.299), p<0.0001] to abuse opioid; graduate level 
was1.3 times more likely [OR = 1.269; 95% CI: .1.011, 1.592, p<0.05] to abuse opioids 
in Indiana compared to high school level. However, the differences across group levels 
showed no significance for primary education level (β = .121, S.E. = .096, Wald = 1.602, 
p = .206), approaching significance for college level (β = .088, S.E. = .047, Wald = 
3.499, p = .061), and significance for secondary level (β = .173, S.E. = .045, Wald = 
14.662, p = .000), and graduate level (β = .238, S.E. = .116, Wald = 4.236, p = 
.040).Therefore, secondary level and graduate level were associated with opioids abusers 
in Indiana compared to high school level. 
Marital status: The model considered ‘Never married’ as a reference category. 
The results demonstrated statistical significance across all marital status categories. The 
results demonstrated that those with ‘divorced, widowed’ marital status compared to 
‘Never married’ were less likely to abuse opioids in Indiana [OR=0.809, 95% CI (0.741, 
0.884), p<0.0001]. The ‘Separated’ marital status was less likely than ‘Never married’ to 
abuse opioids [OR=0.621, 95% CI (0.460, 0.838), p<0.05]; ‘Now married’ marital status 
was less likely than ‘Never married’ to abuse opioids [OR= 0.778, 95% CI (0.704, 
0.860), p<0.0001]. Therefore, ‘Never married’ marital status or single was more likely to 
abuse opioids compared to divorced/widowed, separated, and now married. Nonetheless, 
the model (table 16) showed differences across marital status to be significant for all 
group levels including divorced/widowed (β = -0.212, S.E. = .045, Wald = 21.851, p = 




=-0.251, S.E. = 0.051, Wald = 23.990, p = .000). The results showed the odds ratio for 
marital status to be <1 and a β negative across all marital status levels, suggesting that 
there is a statistical difference between marital status and opioids abuse. Thus, the null 
hypothesis is rejected, and that there is an association between marital status and opioids 
abusers. Basically, single people were at highest risk compared to all other groups. 
Employment status: In this group, full-time was used as the reference category. 
The model showed statistical significance for ‘not in labor force’ and unemployed but did 
not for part-timers. It showed that those in ‘not in labor force’ status was less likely than 
full-timers to abuse opioids [OR=0.736, 95% CI (0.658, 0.822), p<0.0001] (see table 16). 
Also, compared to full-timers, unemployed participants were less likely [OR= 0.749, 
95% CI (0.688, 0.815), p<0.0001] to abuse opioids. Nevertheless, the outcomes indicated 
differences across the group levels to be significant for ‘not in labor force’ (β = -0.307, 
S.E. = .057, Wald = 29.067, p = .000), unemployed (β = -0.289, S.E. = .043, Wald = 
44.969, p = .000), and non-significant for part-timers (β = -0.096, S.E. = 0.064, Wald = 
2.211, p = .137). Thus, full-timers were more likely to abuse opioids in Indiana. 
Gender: The model considered female as the reference category for gender. The 
results demonstrated significance for male sex (see table 16). The results showed that 
compared to female, male was 1.3 times more likely (OR=1.298, 95% CI (1.207, 
1.395), p<0.0001) to abuse opioids. Also, the model showed a β positive (β=0.261, S.E. = 
.043, Wald = 44.969, p = .000). Based on these outcomes, the null hypothesis is rejected. 
Thus, there is an association between gender and opioids abusers and that female had a 




Race: The reference category in this group is whites. The model suggested that 
there was a statistical significance across all race categories. The results suggested that 
compared to whites, Native Americans were 2.7 times more likely [OR=2.667, 95% CI 
(1.220,5.831), p<0.05] to abuse opioid; Blacks or African Americans were 4.6 times 
more likely [OR = 4.583; 95% CI (3.875, 5.421), p<0.0001]; All Others including 
Asians, other single race, two or more races were 1.6 times more likely [OR=1.637, 95% 
CI: 1.372, 1.953, p<0.0001] to abuse opioids in Indiana. It showed that whites had the 
lower risk of reporting opioids abuse in Indiana. Additionally, the differences across 
group levels showed statistical significance for all group levels including Native 
Americans (β = .891, S.E. = .399, Wald = 6.045, p = .014), Blacks or African Americans 
(β = 1.522, S.E. = .086, Wald = 315.768, p = .000), and All Others (β = .493, S.E. = .090, 
Wald = 29.838, p = .000). The model demonstrated the odds ratio for race levels to be 
greater than 1 and a β positive across all race categories. The null hypothesis is rejected; 
thus, there is association between race and opioids abusers in Indiana and that whites 
have lower risk of reporting opioids abuse. 
Age: The reference category in this group is 18-34 years old. The outcomes 
showed statistical significance for all categories. It showed that compared to age group 
18-34, individuals aged 35-44 were 1.2 times more likely [OR=1.212,95%CI (1.114, 
1.319), p<.0001]; 45-54 were 2.2 times more likely [OR=2.226, 95%CI (1.987, 2.495), 
p<.0001]; age group 55 and older were 3.0 times more likely [OR=2.976, 95%CI (2.401, 
3.690), p<.0001] to report opioids abuse in Indiana. The outcomes showed differences 




19.841, p = .000), 45-54 (β = .800, S.E. = .058, Wald = 189.558, p = .000), and 55 and 
older (β = 1.091, S.E. = .0110, Wald = 99.057, p = .000).The null hypothesis is rejected; 
therefore, there is an association between age and opioids abusers in Indiana. Younger 
people have lower risk of reporting opioids abuse. 
Table 16 
 
Multivariate results for association sociodemographic factors and opioids abusers 
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Chi-square and multivariate logistic regression results for association 
sociodemographic factors and treatment completion 
Chi-square results for association sociodemographic and treatment completion 
Chi-square tests were performed examine whether an association exists between 
sociodemographic factors and opioids abusers. The results from Chi-square tests revealed 
that the association between sociodemographic factors and treatment completion was 
significant (p<0.05) for all of them except for race (p>0.05). Findings for education 
demonstrated significance with [Pearson χ2 (4, N = 20822) = 45.690, p = 0.0001, 
Cramer’s V= 0.047] (see tables 17 and table 18). Findings in tables 19 and 20 showed 
significance for marital status with [Pearson χ2 (3, N = 20822) = 8.849, p = 0.031, 
Cramer’s V= 0.021].  
Also, employment status demonstrated the association to be statistically 
significant with [Pearson χ2 (3, N = 20822) = 344.621, p = 0.0001, Cramer’s V= 0.129] 
(see table 21 and table 22). The results from chi-square analysis revealed that 
sociodemographic characteristics of gender was significant with [Pearson χ2 (1, 
N=20822) =39.094, p=0.0001, Cramer’s V=0.043] (see table 23 and table 24). However, 
race did not yield significance [Pearson χ2 (3, N = 20822) = 6.461, p = 0.091, Cramer’s 
V= 0.018] (see table 25 and table 26). Finally, the chi-square analysis between age and 
treatment completion status yielded statistical significance with [Pearson χ2 (3, N = 
20822) = 64.777, p = 0.0001, Cramer’s V= 0.056] (see table 27 and table 28). Thus, these 
findings showed that the sociodemographic factors were associated with treatment 






Chi-square for association between education and treatment completion outcomes 
                                           Value                   df         Asymptotic Significance (2-sided) 
Pearson Chi-Square 45.690a 4 0.000 
Likelihood Ratio 45.294 4 0.000 
Linear-by-Linear 
Association 
41.926 1 0.000 




Effect size for association education and treatment completion outcomes 
 
                                                                     Value                         Approximate Significance 
Nominal by Nominal        Phi 









Chi-Square results for association marital status and treatment completion outcomes 
                                        Value                      df              Asymptotic Significance (2-sided) 
Pearson Chi-Square 8.849a 3 0.031 
Likelihood Ratio 8.815 3 0.032 
Linear-by-Linear 
Association 
1.692 1 0.193 




Effect size for association marital status and treatment completion outcomes 
                                                              Value                          Approximate Significance 
Nominal by Nominal           Phi 












Chi-square results for association employment status and treatment completion outcomes 
                                      Value                  df                    Asymptotic Significance (2-sided) 
Pearson Chi-Square 344.621a 3 0.000 
Likelihood Ratio 339.458 3 0.000 
Linear-by-Linear 
Association 
320.722 1 0.000 




Effect size for association employment status and treatment completion outcomes 
                                                            Value                          Approximate Significance 
Nominal by Nominal           Phi 










Chi-square results for association gender and treatment completion outcomes 
 
 







Pearson Chi-Square 39.094a 1 0.000       
Continuity Correction b 38.901 1 0.000   
Likelihood Ratio 39.323 1 0.000   
Fisher’s Exact Test    0.000 0.000 
Linear-by-Linear 
Association  
39.093 1 0.000   




Effect size for association gender and treatment completion outcomes 
                                                              Value                     Approximate Significance 
Nominal by Nominal           Phi 












Chi-square results for association race and treatment completion outcomes 
                                        Value                       df           Asymptotic Significance (2-sided) 
Pearson Chi-Square 6.461a 3 0.091 
Likelihood Ratio 6.331 3 0.097 
Linear-by-Linear 
Association 
0.987 1 0.0321 




Effect size for association race and treatment completion status 
                                                              Value                          Approximate Significance 
Nominal by Nominal           Phi 










Chi-square results for association age and treatment completion outcomes 
                                        Value                    df              Asymptotic Significance (2-sided) 
Pearson Chi-Square 64.777a 3 0.000 
Likelihood Ratio 62.230 3 0.000 
Linear-by-Linear 
Association 
47.389 1 0.000 




Effect size for association age and treatment completion outcomes 
                                                            Value                          Approximate Significance 
Nominal by Nominal           Phi 










Multivariate logistic regression results for association between 
sociodemographic factors and treatment completion 
The researcher applied a multivariate logistic regression analysis to examine the 
association between sociodemographic factors (education, marital status, employment 
status, gender, race, and age) and opioids abusers. The dependent or outcome variable 
considered in this analysis was treatment completion status. The predictor variables 
included education, marital status, employment status, gender, race, and age. The 
multivariate logistic regression model in table 29 considered the reference category for 
education, marital status, employment status, gender, race, and age as high school, never 
married, full-time, female, whites, and age group 18-34, respectively. 
Education: The baseline in this category is high school level. The model 
suggested college and graduate level to be statistically significant. Whereas it did not 
showed significance for primary and secondary levels. It showed that compared to high 
school level, those with college level were 0.912 less likely [OR=0.912, 95% CI (1.219, 
1.752), p<0.05]; individuals with graduate level were 0.731 less likely [OR=0.731, 95% 
CI (0.614, 0.871), p<0.0001] to complete treatment. However, the model did not show 
significance for primary and secondary levels. Additionally, differences across group 
levels showed non-significance for primary (β = 0.151, S.E. = .087, Wald = 3.061, p = 
.080), secondary (β = .066, S.E. = .039, Wald = 2.895, p = .089); significance for college 
(β = -0.092, S.E. = .040, Wald = 5.222, p = .022) and graduate (β = -0.313, S.E. = .089, 




graduate had a significantly lower likelihood of treatment completion compared to high 
school. Further research is needed to confirm or repudiate these findings. 
Marital status: In this group, the reference category is ‘never married.’ The 
outcomes suggested that only divorce/widowed marital status showed significance. It 
demonstrated that compared to ‘never married’ marital status, those with 
divorced/widowed status were 1.1more likely [OR=1.132, 95% CI (1.046, 1.225), 
p<0.005] to complete treatment. However, it did not show significance for separated 
[OR=0.978, 95% CI (0.754, 1.267), p<0.865] and for ‘now married’ [OR=0.997, 95% CI 
(0.912, 1.089), p<0.943]. There is no association between marital status and treatment 
completion. 
Employment status: Full-time is considered the reference category in the model. 
The results showed all categories to be statistically significant. It showed that compared 
to full-timers, individuals in ‘not in labor force’ were 2.0 times more likely [OR=2.042, 
95% CI (1.853, 2.252), p<0.0001], unemployed were 1.8 times more likely [OR=1.785, 
95% CI (1.662, 1.916), p<0.0001], and part-timers were 1.4 times more likely 
[OR=1.406, 95% CI (1.269, 1.557), p<0.0001] to complete treatment. It meant that full-
timers have lower treatment completion rate than ‘not in labor force’, unemployed, and 
part-timers. Further, the differences across levels showed significance for ‘not in labor 
force’ (β = 0.714, S.E. = .050, Wald = 205.935, p = .000), unemployed (β = .579, S.E. = 
.036, Wald = 255.460, p = .000); part-timers (β = 0.341, S.E. = .052, Wald = 42.622, p = 




hypothesis is rejected; thus, there is an association between employment status and 
treatment completion. 
Gender: The reference category in gender group is female. The model showed 
significance for male (table 29). It demonstrated that compared to females, males were 
0.923 times less likely [OR=0.923, 95% CI (0.866, 0.983), p<0.05] and [β = -.081, S.E. = 
.033, Wald = 6.108, p = .013] (see table 29). Thus, females had higher treatment 
completion rate than males. 
Race: The reference category chosen in this group is whites. The overall logistic 
regression model showed that ‘All others’ were statistically significant (see table 29). It 
showed that compared to whites, ‘All Others’ were 0.9 times less likely to complete 
treatment with [OR=0.852, 95% CI (0.743, 0.976), p< 0.05] and [β = -.161, S.E. = .069, 
Wald = 5.348, p = .021]. However, the results did not show significance for ‘Native 
Americans’ [OR=0.822, 95% CI (0.515-1.312), p> 0.05] and for ‘Blacks or African 
Americans’ [OR=1.049, 95% CI (0.960, 1.147), p>0.05]. Whites were more likely to 
have higher treatment completion rate. 
Age: The reference category for age is age group 18 to 34. The overall model 
showed significance across all categories. It suggested that compared to age group 18-34, 
individuals aged 35-44 were 0.517 times less likely [OR=0.517, 95% CI (0.452-0.591), 
p<0.0001] with OR<1. Also, it showed that age group 45 to 54 were 0.833 times less 
likely [OR=0.833, 95% CI (0.765-0.907), p<0.0001]; age group 55 and older were 0.918 
times less likely [OR=0.918, 95% CI (0.851-0.990), p<0.05] to complete treatment 




significant for age group 35-44 (β = -0.086, S.E. = .039, Wald = 92.851, p = .000); age 
group 45-54 (β = -0.183, S.E. = .043, Wald = 17.786, p = .000); and age group 55 and 
older (β = -0.659, S.E. = .068, Wald = 4.919, p = .027). Therefore, the null hypothesis is 
rejected, and I conclude that there is a negative association between age and treatment 
completion. This suggested that younger people have higher treatment completion rate 
than older people. That means, when you get older, it is less likely to complete treatment. 
Table 29 
 
Multivariate results for association between sociodemographic factors and treatment 
completion outcomes 
Variables B S. E Wald df Odds 
ratio 
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Research Question 2 
Descriptive statistics for association health insurance vs. treatment completion 
Descriptive statistics presented in table 28 for both variables (health insurance 
coverage and treatment completion) revealed N= 20822 valid cases processed and zero 
missing cases. The sample comprised of N=6926 individuals aged 18 and older who were 
uninsured, accounting for 33.3%. While N= 13896 participants who were insured with 
any insurance coverage, including private or government, representing 66.7% of the total 
sample (Table 28). Among participants, there were a total of N=14631 who did not 
complete their treatment accounting for 70.3%. There were dropped out of treatment, 
terminated by the center, transferred to a new facility or program, incarcerated, or dead. 
Those who did complete treatment successfully represented 29.7%. 
Table 30 
 
Descriptive statistics of health insurance coverage and treatment completion outcomes 
Variables 
 
Category Frequency (N) Percent (%) 






Treatment Completion stat 
 












Table 31 showed that among individuals who did not complete treatment for 
opioid abuse, the expected count for "uninsured" was 4866.7, while the observed count 
was 4521. For those insured, the expected count was 9764.3, while the observed count 
was 10110. Among individuals who completed the treatment for opioid abuse (treatment 
completed), the expected count for "Uninsured" was 2059.3, and the observed count for 
that same group was 2405. For the "Insured" group who did complete their treatment, the 
expected count was estimated at 4131.7, and the observed count was 3786.  
The chi-square test results were shown in table 32. The findings demonstrated the 
association between health insurance coverage and successful treatment completion was 
statistically significant with [Pearson χ2 (1, N = 20822) = 123.750, p = 0.0001, Cramer’s 
V= 0.77)] (see table 32 and table 33). This outcome in table 32, with a p-value less than 
0.05, indicated strong evidence against the null hypothesis. Therefore, the null hypothesis 
was rejected, and the alternative hypothesis was accepted. This meant that there is an 
association between health insurance coverage and treatment completion and that having 
health insurance coverage predicted successful treatment completion. To understand the 
extent of the association between health insurance coverage and treatment completion, 
Cramer's V was run, and the result was presented in table 33. Cramer's V described the 
association's effect size, and the table showed the value to be 0.77. Therefore, the effect 
size of the association between health insurance coverage and treatment completion was 






Crosstab between health insurance coverage and treatment completion outcomes 
                                        Health insurance status 
                                   Uninsured          Insured             Total 
Treatment Completion status      Treatment not completed Count           4521                  10110               14631 
                                                                  Expected Count      4866.               79764.3             14631.0 
                                                             Treatment completed    Count                2405                  3786                 6191 
                                                            Expected Count           2059.3              4131.7               6191.0 
Total                                                                         Count                6926                  13896                20822 




Chi-square results for association between health insurance coverage and treatment 
completion outcomes 









123.750a 1 .000   
Continuity Correction b 123.392 1 .000   
Likelihood Ratio 122.054 1 .000   
Fisher’s Exact Test    .000 .000 
Linear-by-Linear 
Association 
123.744 1    






Effect size for association health insurance coverage and treatment completion outcomes 
 










N of Valid 
Cases 
 20822    
 
Bivariate logistic regression  
The inquirer ran a bivariate logistic regression to evaluate the association between 
health insurance coverage and treatment completion (see table 34). It is expected that 
having health insurance coverage (being insured) can have higher chance of treatment 
completion (Feder et al., 2019).The reference category in this analysis was ‘Insured.’ The 
outcomes of the analysis demonstrated statistical significance. It showed that compared to 
insured, uninsured individuals were less likely [OR=0.704, 95% CI (0.662, 0.749), 
p<0.0001] to complete treatment. The results also showed that (β =- 0.351, S.E. = .032, 
Wald = 123.219, p = .000) [table 34]. That meant that compared to ‘Insured,’ people who 
were uninsured (lacking insurance coverage) were 0.704 times (30%) less likely to 
complete opioids treatment. The model demonstrated that the null hypothesis is rejected 
and that having health insurance (being insured) is associated with treatment completion. 






Bivariate results for association between health insurance coverage and treatment 
completion outcomes 
Variable B S. E Wald df Odds 
ratio 
95% CI P 
Uninsured -
0.351 
0.032 123.219 1 0.704 0.662-0.749 0.000 
Insured (Ref) -------   -------    
 
Research Question 3 
Multivariate logistic regression between health insurance and treatment completion 
outcomes after adjusting for sociodemographic factors 
 
The investigator conducted a multivariate logistic regression to examine the 
association between health insurance coverage and treatment completion after adjusting 
for age, gender, race, marital status, employment status, and education (Table 35). The 
outcome variable considered in this analysis was successful treatment completion. The 
predictor variable in this multivariate logistic regression was health insurance with 
sociodemographic factors adjusted. The investigator added education, marital status, 
employment status, gender, race, and age to the model. The results suggested that 
education was not associated with treatment completion. It did, however, showed 
significance with college and graduate. It demonstrated that compared to high school 
level, college were less likely [OR=0.915, 95% CI (0.846, 0.990), p<0.05], and graduate 




Besides, the outcomes revealed that marital status did not show significance. But it 
showed that compared to single, divorced/widowed were 1.140 times more likely 
[OR=1.140, 95% CI (1.053, 1.234), p<0.05] to complete treatment. Nonetheless, the 
results demonstrated significance for employment status. It did show that compared to 
full-timers, not in the labor force were 1.9 times more likely [OR=1.929, 95% CI (1.748, 
2.128), p<0.0001]; unemployed were 1.8 times more likely [OR=1.801, 95% CI (1.677, 
1.934), p<0.0001], and part-timers were 1.4 times more likely [OR=1.392, 95% CI 
(1.256, 1.542), p<0.0001] to complete treatment. Findings revealed that gender was not 
significant. Similarly, the results showed that race was not significant (p>0.05). It did 
nonetheless showed significance for age across all levels. That meant, compared to age 
group 18-34, age group 35 to 44 had lower likelihood [OR=0.509, 95% CI (0.445, 
0.582), p<0.0001; age group 45 to 54 had lower likelihood [OR=0.826, 95% CI (0.759, 
0.899), p<0.0001; and age group 55 and older had lower likelihood [OR=0.911, 95% CI 
(0.845, 0.983), p<0.0001] to complete treatment since OR is less than 1.00. Most 
importantly, the model showed that compared to insured, uninsured 0.722 times less 
likely [OR=0.722, 95% CI (0.678, 0.770), p<0.0001] to complete treatment. It also 
showed that after sociodemographic factors were adjusted, the OR increased from 
[OR=704, 95% CI (0.662-0.749), p<0.0001] to [OR=0.722, 95% CI (0.678, 0.770), 
p<0.0001]. I concluded an association exists between health insurance coverage and 
treatment completion and that employment status and age were confounders. Though, 







Multivariate results for association health insurance coverage and treatment completion 
outcomes after adjusting for sociodemographic factors 
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This study design examined the association between sociodemographic factors 
(i.e., age, gender, race, education, marital status, and employment status) and treatment 
completion for opioids abusers in Indiana. The researcher applied descriptive statistics 
such as frequency distribution to display data summary. The study further assessed the 
association between health insurance coverage and treatment completion for opioid 
abusers in Indiana after controlling for sociodemographic factors using chi-square and 
logistic regression. A sample (N=20822) was used, accounting for 59.9% males and 
40.1% females aged 18 and older. Almost half of the sample had a high school level 
(49%), and slightly over 20% had a college degree or higher. Individuals who were never 
married represented the sample's bulk (63%), and 22% were divorced/widowed. 
Descriptive statistics showed that 41% of the sample were unemployed, while 32% had a 
full-time job, and 11% had part-time employment. Most of the sample were Whites 
(81%) and Blacks or African Americans (14%). Also, participants in the study were aged 
18-34 years old (52%), 35-44 (25%), and 45-54 (17%). 
Basic chi-square tests performed exhibited a statistically significant association 
between sociodemographic factors and opioids abusers across all levels. The researcher 
conducted a multivariate logistic regression analysis to assess the association between 
sociodemographic characteristics and opioids abusers. The results demonstrated 
statistical significance (p<0.05) for divorced or widowed/ separated/now married 
compared to never married; male compared to female; Native Americans/ Blacks or 




younger. Similarly, the outcomes revealed that never married were more likely to report 
opioids abuse, and that being females, whites, and younger showed lower risk of 
reporting opioids abuse in Indiana. Additionally, a multivariate logistic test for the 
association between sociodemographic factors and treatment completion showed 
significance (p<0.05) for not in labor force/unemployed/ part-timers compared to full-
timers; male compared to female; older age groups compared to younger age group (18-
34).The overall model revealed that being full-timers and younger is linked with lower 
treatment completion rate. However, it demonstrated that being females is associated 
with higher treatment completion rate. A bivariate model used to assess the association 
between health insurance coverage and treatment completion status showed significance 
and that being insured contributed to treatment completion outcome. After 
sociodemographic attributes of education, marital status, employment status, gender, 
race, and age were added to the model, health insurance coverage still showed 
significance. It showed that employment status, and age might be confounders on the 
association.  The next section discussed interpretation of the results, limitations of the 




Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
Substance abuse has been a longstanding health issue across the United Stated 
(Gomes et al., 2018). In Indiana, in 2017, opioid abuse had claimed 1,700 lives due to 
overdose Richard Fairbanks Foundation, 2018). Statistics showed individuals aged 18 
and older were highly affected by substance abuse (NIDA, 2018). This study sought to 
investigate the association between sociodemographic factors (i.e., age, gender, race, 
marital status, employment status, and education level) and successful treatment 
completion outcomes among opioid abusers in Indiana aged 18 and older using 2017 
Treatment Episode Data Set Discharges (TEDS-D) that can be accessed through the CDC 
WONDER. The current study also investigated the association between health insurance 
coverage and treatment completion outcomes for opioids abusers in Indiana among 
individuals aged 18 years and older. The study was conducted to advocate the expansion 
of health insurance coverage for substance abuse patients (including opioids) and 
improve treatment completion outcomes and access to care while reducing morbidity and 
mortality due to opioid abuse among Indiana residents. 
A sample size of N=20922 was used in this analysis. Descriptive statistics showed 
that the sample was made up of 60% males and 40% females aged 18 and older. Data 
summary demonstrated individuals with high school levels accounted for 49%, secondary 
(24%), and those with college degrees accounted for slightly more than 24%. In this 
sample, 63% were never married, 22% were divorced/widowed, and 14% were married. 




job, while 41% were unemployed, 16% were not in labor force. The sample was made up 
of Whites (81 %,) Blacks or African Americans (14 %,) Native Americans (slightly over 
1 %,) and the rest represented "All others." Moreover, the sample showed that 30% did 
report substance abuse. Additionally, there were 30% of individuals who did complete 
treatment in the sample. Pearson chi-square between sociodemographic factors and 
opioids abusers showed significance across all levels with a p-value less than 5%. 
Nevertheless, basic Chi-square tests between the same sociodemographic attributes and 
treatment completion showed statistical significance at all levels except for race. 
Meaningful findings suggested a statistical significance correlation (p-value less 
than 5%) between marital status, gender, race, age, and opioids abusers. The results 
revealed that never married or single were more likely to report opioids abuse while 
females, whites, and younger people had a lower risk of reporting opioids abuse in 
Indiana. Similarly, the outcomes showed the association between employment status, 
gender, age, and treatment completion to be statistically significant. It demonstrated that 
females had a higher treatment completion rate, whereas full-timers and younger people 
had a lower treatment completion rate. Furthermore, the association between health 
insurance coverage and treatment completion was significant, and that uninsured 
individual had a lower chance of completing treatment. It suggested that marital status, 
employment status, and age were confounders in the association. The next sections will 
discuss the interpretation of my findings, the study's limitations, recommendations, 




Interpretation of the Findings 
This research fills the gaps by assessing the association between the selected 
sociodemographic factors and treatment completion status for opioids abusers. Also, it 
sought to evaluate the correlation between health insurance coverage and treatment 
completion status after sociodemographic factors were adjusted. 
Research Question 1: Sociodemographic factors and treatment completion for 
opioids abuse 
The findings were statistically significant for secondary and graduate levels. The 
outcomes approached significance for college level. That meant, compared to high 
school, secondary level was 1.2 times more likely [OR=1.189, 95% CI (1.088, 
1.299), p<0.0001]; graduate-level was 1.3 times more likely [OR = 1.269; 95% CI: 
.1.011, 1.592, p<0.05] to abuse opioids. It demonstrated that when people are more 
educated, they are more likely to engage in substance abuse.  These findings were 
different from studies by Gomes et al. (2018); Gul & Sharna., 2017; and Swendsen et al., 
2009), which showed that education was strongly associated with substance abuse.  
Concerning marital status, findings revealed that those with 'divorced, widowed' 
marital status were less likely to abuse opioids compared to 'never married.' Similarly, 
'Separated' marital status was less likely than 'Never married' to abuse opioids; 'Now 
married' marital status was less likely than 'Never married' to abuse opioids. Therefore, 
'Never married' marital status was more likely to abuse opioids than divorced/widowed, 
separated, and now married. The results showed the odds ratio for marital status 




were consistent findings from Lamptey (2005); and Tavares et al.(2004). Other studies 
found single or never married to be a predictor of opioid abuse (Ray et al., 2017; and 
Swendsen et al., 2009). It could be that long-term opioid abusers are less likely to find 
spouses; thus, they are more likely to stay single, and some never get to marry. However, 
further research is needed to confirm these findings. 
The results demonstrated that employment status was statistically significant 
across ‘not in labor force’ and unemployed, but non-significant for part-timers. It was 
assumed that the more people hold full-time employment, the less likely they engage in 
substance abuse activities. But the outcomes revealed that compared to full-timers, 
individuals in ‘not in labor force’ were less likely to report opioids abuse. Similarly, the 
results suggested that unemployed people were less likely than full-timers to abuse 
opioids. The outcomes represented a reversal that found full-time employment to have 
protective effects against drug problems (Simoni-Wastila& Strickler, 2011). However, in 
a previous study by Simoni-Wastila& Strickler (2011), the investigators did not find full-
time and part-time employment status to be associated with opioids abuse. Besides, 
Henkel (2011) and Tavares et al. (2004) demonstrated unemployment to be a significant 
risk factor for substance abuse and dependence. Henkel (2011) further elaborated that 
unemployment can augment the risk of relapse after drug addiction treatment. More 
investigation is needed to understand the variations for sociodemographic employment 
status. 
The current study results found that males have a higher risk of reporting opioids 




had a greater likelihood than female to abuse opioids (Gomes et al., 2018; Lamptey, 
2005; Ray et al.,2017; and Wisniewski et al. (2008). However, McCabe et al. (2017)) 
findings were contradictory and found that females had a higher risk of abusing opioids 
than male individuals. Another survey did not find any difference with gender (Swendsen 
et al., 2009). More study is needed to validate the current results. 
Moreover, the results showed significance for all racial levels (p<0.05). 
Compared to whites, Native Americans were 2.7 times more likely to abuse opioids; It 
demonstrated that Blacks or African compared to whites were 4.6 times more likely to 
report opioids abuse. Compared to ‘All Others’ including Asians, other single race, two 
or more races were 1.6 times more likely to abuse opioids in Indiana. It showed that 
whites have a lower risk of reporting opioids abuse in Indiana. Other studies found that 
white people were more likely to abuse opioids (Lamptey, 2005; Ray et al., 2011; 
Simoni-Wastila& Strickler). However, other studies did not find any difference. 
Furthermore, sociodemographic characteristic of age was significantly correlated 
with opioid abuse in this study. The outcomes revealed that compared to the age group 
18-34, individuals aged 35-44 were 1.2 times more likely to report opioids abuse. Age 
groups 45-54 were 2.2 times more likely to report opioids abuse than individuals aged 
18-34. Also, people aged 55 and older were 3.0 times more likely to report opioids abuse 
compared to the age group 18-34. These findings were consistent with the results from 
the surveys conducted by Ray et al. (2011) and Simoni-Wastila& Strickler (2011). On the 
other hand, some surveys revealed that drug abuse was more prevalent in adolescents 




Wisniewski et al., 2008) and in younger people (Lamptey, 2005; Swendsen et al., 2009 
and Tavares et al., 2004). Nonetheless, more investigation is needed to confirm these 
findings. 
The association between the selected sociodemographic factors and treatment 
completion status had been assessed (see table 29).  Findings revealed that college and 
graduate-level were statistically significant. However, the results showed non-
significance for primary and secondary levels. It meant that compared to the high school 
level, individuals with college-level were 0.912 more likely to complete treatment. 
Similarly, individuals with graduate-level were 0.731 more likely to complete treatment. 
However, the model did not show significance for primary and secondary levels. This 
study's results aligned with previous findings from Newton-Howes & Stanley (2015). 
Also, surveys suggested that failure to complete treatment was positively associated with 
lower educational attainment (Brown, 2010; Knight et al., 2009). There is a need for 
more investigation to validate the results of this study.  
Regarding marital status, the outcomes suggested that only individuals with 
divorce/widowed marital status were significant. It demonstrated that compared to 'never 
married' marital status, individuals having divorced/widowed status were 1.1 more likely 
to complete treatment. Separated and now married were more likely to complete 
treatment than never married or single, but these differences were not significant. 
Previous studies found different outcomes and that Whites were more likely to complete 




Besides, the results of this study yielded a statistical significance for employment 
status across all levels. It showed that compared to full-timers, individuals in 'not in labor 
force' were 2.0 times more likely to complete treatment; Unemployed were 1.8 times 
more likely, and part-timers were 1.4 times more to complete treatment when compared 
to full-timers. This could be related to lack of social support. Some studies found no 
difference between employment status and treatment completion (Bazargan-Hejazi et al., 
2016 and Suntai et al., 2020), and another found unemployed to be predictive of 
treatment completion (Brown, 2010). Further research is needed. 
Moreover, the results demonstrated that males were 0.923 times less likely to 
complete treatment than their counterparts' females. This meant that females have a 
higher treatment completion rate than males. The results were consistent with previous 
research conducted by Guerrero et al. (2014). On the contrary, other studies found that 
males had higher treatment completion rates than females (Bazargan-Hejazi et al., 2016; 
and Suntai et al., 2020). It is common to believe that women were more likely to receive 
services that match their needs than men. Nonetheless, Brown's (2020) survey did not 
find any difference between gender and treatment completion. 
The outcomes of the study showed race not to be statistically significant. It does, 
however, showed significance for the ‘All Others’ race group. It meant that compared to 
whites, ‘All Others’ (Asians, other single race, and two or more races) were 0.918 times 
less likely to complete treatment. Other findings from Suntai et al. (2020) revealed that 




by Brown (2010) found non-white ethnicity to be strongly correlated with treatment 
completion outcomes compared to whites. 
Finally, the results of the study demonstrated age to be statistically significant at 
all levels. It showed that compared to age group 18-34, individuals aged 35-44 were 
0.517 times less likely to complete treatment. Also, age groups 45 to 54 were 0.833 times 
less likely than age group 18-34 to complete treatment. Compared to age group 18-34, 
individuals aged 55 and older were 0.918 times less likely to complete treatment. The 
overall results demonstrated that younger people have a higher treatment completion rate 
than older people since the OR for all level was less 1.00. Further research could help 
figure out the reasons for this shift. Evidence suggested that older people would have 
better treatment outcomes than younger. Because as reported in a survey, older people do 
not face system-level barriers for treatment since they generally possessed public 
insurance coverage through Medicare, Tricare, and VA (Choi et al., 2014). The outcomes 
in this study showed that younger had higher treatment completion rates compared to 
older people. Previous research recognized some barriers that led to similar findings. It 
had been shown that substance abuse treatment barriers for older people included lack of 
readiness to discontinue use and lack of knowledge about services, treatment, and 
programs (Choi et al., 2014). Conversely, Choi et al. (2014) noted that younger people 
faced substance abuse treatment barriers such as cost, stigma, and confidentiality 
concerns. The study outcomes could be due to education. Tackling the epidemic of 




Education is the primary focus to help individuals understand the health consequences of 
opioid abuse (Indiana State Department of Health, 2018). 
On the other hand, this study outcome were different from Suntai et al. (2020,) 
whose findings suggested that older people have higher treatment completion rates for 
substance abuse. Although older adults had higher odds of substance abuse treatment 
completion, the multivariate logistic regression model suggested differences among racial 
groups (Suntai et al., 2020). The study noted that Black older adults had a lower 
likelihood of completing substance use treatment than their White counterparts [OR= 
0.630]. It showed that the difference had deepened between whites and Blacks subjects, 
with Blacks older adults being 34% less likely to complete treatment than Whites (Suntai 
et al., 2020). 
Research Question 2: Association of Health insurance and treatment completion  
The study outcomes showed significance for health insurance coverage. It demonstrated 
that compared to insured, uninsured individuals were 0.704 times less likely to complete 
treatment. These study findings showed that ‘Uninsured’ individuals have a lower chance 
of completing the treatment than insured individuals. Previous studies found an 
association between health insurance coverage and successful treatment completion 
(Allcock et al., 2019; Mojtabai et al., 2020 and Olfson et al., 2018;). Research conducted 
by Mojtabai et al. (2020) reported that numerous privately insured adults with drug use 
disorders in the United States were not covered for drug use treatment. However, the 
article suggested that the Affordable Care Act's enaction introduced new benefits to cover 




correlation between having drug use treatment coverage and receiving treatment, 
Mojtabai et al. (2020) found that coverage was statistically significantly correlated with 
receiving treatment [OR= 2.09, 95% CI = 1.61–2.72, p < .001]. Additionally, the 
investigators examined such association in two simulated situations with participants who 
ignored their coverage (in one scenario, none of the participants had coverage and, the 
second scenario assumed that all participants had coverage.) The outcomes revealed that 
the association of drug treatment coverage with actual receipt of treatment was 
statistically significant in both scenarios yielding [OR = 2.46, 95% CI = 1.91–3.16, p < 
.001] and [OR = 1.46, 95% CI = 1.14–1.88, p = .004], respectively (Mojtabai et al., 
2020). Olfson et al. (2019) found a significant increase in private insurance use among 
individuals aged 19-25 (8%) and 26-35 years old (1.2%) between 2008-2010 and 2011-
2013. But the increase within the two groups did not differ between 2011-2013 to 2014-
2016 with 3.2% and 3.8%, respectively. Also, a research conducted by Allcock et al. 
(2020) found that health insurance was strongly associated with both outpatient and 
inpatient care [OR: 1.28; 95% CI: 1.08–1.52; p = 0.005] and [OR: 1.52; 95% CI: 1.26–
1.82; p < 0.001]. However, the studies' results noted the utilization of health insurance 
coverage to be low (Allcock et al., 2019; Motjabai et al., 2020 and Olfson et al., 2018). 
Also, the more health insurance coverage people have the better chance of 
completing treatment for substance abuse. Having health insurance coverage is a strong 
predictor of drug treatment completion. Cummings et al. (2014) assessed the association 
between private insurance coverage for substance use disorders and specialty treatment 




who did not know their coverage status for drug dependence had a lower likelihood of 
receiving drug treatment from specialty services compared to the uninsured (Cummings 
et al., 2014). However, Cummings et al. (2014) found alcohol addiction strongly 
correlated with private insurance use (Cummings et al., 2014). Evidence suggested that 
many adults remained without health insurance coverage (Allcock et al., 2019; 
Cummings et al., 2014; Mojtabai et al., 2020;  Olfson et al., 2018). According to 
Cummings et al. (2014), about 25% of adults with alcohol dependence, and 34% of them 
with drug dependence without insurance coverage. But Choi et al. (2020) noted that older 
adults were usually covered through Medicare. Health insurance coverage is vital for 
substance users and expanding health insurance coverage to these populations can help 
improve their overall health outcomes. The expansion of coverage through the 
implementation of the Affordable Care Act (ACA) could well achieve this objective 
(Cummings et al., 2014; Huhn et al., 2020; Mojtabai et al., 2020). 
Research Question 3: Health insurance coverage versus treatment completion 
after controlling for sociodemographic factors. 
After sociodemographic factors were adjusted, the results still demonstrated 
significance between health insurance coverage and treatment completion among 
participants in this study. The results showed that compared to insured, uninsured 0.733 
times less likely [OR=0.733, 95% CI (0.688, 0.781), p<0.0001] to complete treatment. 
After sociodemographic factors were adjusted, the OR increased from [OR=704] to 
[OR=0.733]. I concluded an association between health insurance coverage and treatment 




Limitations of the study 
Despite its contribution noted above, the present secondary data analysis and 
cross-sectional study might have several limitations to be considered. Firstly, data about 
drug use treatment and coverage were self-reported. This could lead to recall and social 
desirability biases. Although evidence that TEDS-D datasets have high reliability and 
validity, it is possible that some respondents might report misleading responses. Drugs 
are also considered a societal issue and collecting accurate information from individuals 
dealing with drug use might be challenging. Inaccurate answers to the primary research 
questions could lead to bias, so it is essential to comprehend the dataset's accuracy being 
analyzed (Boo & Froelicher, 2013). There was potential for information and selection 
biases. Cummings et al. (2014) noted that health insurance status is self-reported, and the 
comprehensiveness of insurance coverage for drug treatment could not be corroborated. 
Another survey suggested that insurance coverage for substance use treatment depends 
on the type of services provided at the treatment settings. Understanding insurance 
coverage for drug abuse can lead a person to seek drug use treatment (Mojtabai et al., 
2020). Further, the available datasets did not reveal information related to factors that can 
influence treatment completion, like existing community resources such as social support 
(Bazargan-Hejazi et al., 2016). It is imperative to assess the association of insurance 
coverage with these treatment characteristics in future research. 
Secondly, the datasets were derived from submissions by individual programs that 
received funding from the States. This can hinder data quality collection because 




with substance abuse issues as possible. Suntai et al. (2020) noted that only state-funded 
treatment program outcomes were submitted, which could exclude private treatment 
programs, private jails, and other programs such as Alcoholics Anonymous (AA). Stahler 
& Menni (2020) noted that there might be variation in data quality and the way treatment 
completion was determined at the program level. Therefore, funding restriction might 
lead to the State's ability to only focus its efforts on the populations at their reach, leaving 
out many substance abusers without coverage. The available dataset in this study was 
based on admissions, not individuals. Many survey entries might have been reported as 
admissions for the same patient instead of the client itself. This could influence the 
overall outcomes as well as their reliability and validity. 
Third, non-responsive and missing information might tilt the direction of the 
survey and might impact the results. The national TEDS contained many missing values. 
However, in the final analysis of the extracted Indiana datasets, a simple random sample 
method had been employed. All missing values were removed during the analysis to 
minimize the impact of missing values and increase the study outcomes' reliability and 
validity. Consequently, this study's reliability could be similar to the TEDS-D national 
survey on substance abuse. 
Lastly, the study's cross-sectional nature represents a limitation because data were 
collected at one specific point in time, and the causality of the association cannot be 
established. The use of public and de-identified datasets represents a limitation in this 
study. Evidence showed that the major threats to the reliability and validity of secondary 




Froelicher, 2013). Issues may arise from the sampling method used, data collection, non-
response, and missing data. Because the researcher did not participate in the initial 
research design and data collection and because of the nature of this study, the causality 
of the association between sociodemographic factors and treatment completion as well as 
the association between health insurance and treatment completion could not fully be 
assessed (Allcock et al., 2019). It has been demonstrated that the main threats to the 
reliability and validity of secondary data analysis derived from the accuracy of the 
approaches used during the primary data collection. However, adequate measures were 
taken, including sampling strategy and handling of missing data had been employed to 
minimize potential bias during the analytic phase of this study. 
Recommendations 
Based on the outcomes of this research, the investigator had formulated various 
recommendations. First, a statewide longitudinal survey on the association between 
sociodemographic attributes and treatment completion for opioids abuse should be 
conducted to recognize the most predictor attributes and develop policies to address the 
problem. Additionally, a statewide longitudinal survey should be conducted to investigate 
the association between health insurance coverage and treatment completion for opioids 
abuse. The state should also enact strict laws to control opioids misuse through medical 
prescriptions and enforce them rigorously. The state should promote population-based 
education to increase awareness among those most affected. Interdisciplinary efforts 
should be fostered by involving all sectors to tackle the ongoing opioids abuse in Indiana 




Further, the state must expand health insurance coverage for individuals without 
coverage for opioids specialty treatment entry through the Affordable Care Act advocacy 
to improve treatment retention and completion. The federal government must allocate 
enough funding for states to address this deadly public health issue. The study 
recommends all healthcare professionals (e.g., physicians, nurses, counselors, and 
emergency responders) know how to respond to overdose crises to reduce mortality rates. 
Simultaneously, the integration of substance abuse screening at primary care settings 
should be among doctors' and nurses' priorities to recognize early signs and initiate 
referral procedures for immediate care or interventions. Finally, the association of health 
insurance coverage with treatment completion and the relationship between 
sociodemographic and opioids abuse need to be explored further to better address this 
public health issue in the state of Indiana. 
Positive social change implications 
The study's findings suggested that most of the selected sociodemographic factors 
(e.g., education, marital status, employment status, gender, race, age) were predictors of 
opioids abuse in Indiana. Targeting these factors through various intervention plans, 
including a screening at primary care settings and population-based education, could 
promote positive social change in Indiana. Special attention should be given to males, 
minorities, single, full-timers, and older people. Simultaneously, understanding predictors 
for treatment completion and emphasizing more on full-timers, males, minorities, older 
people who experienced lower treatment completion rates compared to younger could 




Also, strengthening and strictly enforcing the existing policies related to opioids 
prescriptions help promote positive social change in the communities. The study 
demonstrated that having health insurance coverage was an independent predictor of 
treatment completion. Hence, expanding insurance health insurance coverage among 
target populations through Medicaid, Medicare, private, or employers might help 
improve entry to opioids specialty treatment and promote positive social change among 
those most affected. Health insurance could be scaled-up through community 
engagement approaches that employ the media and other advocacy tools. 
Conclusion 
Opioid abuse remains a pressing public health issue in Indiana. The study 
suggested marital status, gender, race, and age were the most predictors of opioids abuse 
in Indiana. It further demonstrated that employment status, gender, and age were most 
likely to predict successful treatment completion. Finally, people with health insurance 
coverage had a higher chance of completing treatment than uninsured even after 
sociodemographic factors were adjusted. Implementing more screening of individuals at 
risk, promoting population-based education, advocating for health insurance coverage, 
and enforcing the existing policies vigorously could promote positive social change 
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Appendix A: List of Abbreviations 
ADOM: Alcohol and DRUG Outcome Measure 
AUD:  Alcohol use disorder 
DALY disability-adjusted life-years 
DAWN: Drug Abuse Warning Network  
CDC: Centers for Disease Control and Prevention 
ISDH: Indiana State Department of Health 
YLL: Years of life lost 
MC: Marion County 
MOUD: Medication for Opioid Use Disorder 
MTF: Monitoring the Future 
NHAMCS: National Hospital Ambulatory Medical Care Survey 
NSDUH: National Survey on Drug Use and Health  
NIDA: National Institute on Drug Abuse 
NUPO: Nonmedical use of prescription opioids  
OPA: Opioid prescription abuse  
OPR: Opioid pain reliever  
OUD: Opioid use disorder  
SCT: Social cognitive theory  
UNODC: United Nations Office on Drugs and Crime or UNODC 
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Appendix C: SPSS Outputs 
Education 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Primary 782 3.8 3.8 3.8 
Secondary 4990 24.0 24.0 27.7 
College 4235 20.3 20.3 48.1 
Graduate 586 2.8 2.8 50.9 
High School 10229 49.1 49.1 100.0 
Total 20822 100.0 100.0  
 
Marital status 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Divorced, widowed 4476 21.5 21.5 21.5 
Separated 284 1.4 1.4 22.9 
Now  married 2928 14.1 14.1 36.9 
Never married 13134 63.1 63.1 100.0 
Total 20822 100.0 100.0  
 
EMPLOY group 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Not in labor force 3398 16.3 16.3 16.3 
Unemployed 8479 40.7 40.7 57.0 
Part-time 2355 11.3 11.3 68.4 
Full-time 6590 31.6 31.6 100.0 
Total 20822 100.0 100.0  
Biologic sex 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Male 12474 59.9 59.9 59.9 
Female 8348 40.1 40.1 100.0 
Total 20822 100.0 100.0  
 




 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Native Americans 80 .4 .4 .4 
Blacks or African Americans 2897 13.9 13.9 14.3 
All Others 1026 4.9 4.9 19.2 
Whites 16819 80.8 80.8 100.0 
Total 20822 100.0 100.0  
 
AGE Group 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid 55 and older 1182 5.7 5.7 5.7 
45-54 3584 17.2 17.2 22.9 
35-44 5200 25.0 25.0 47.9 
18-34 10856 52.1 52.1 100.0 
Total 20822 100.0 100.0  
 
Health to group 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Uninsured 6926 33.3 33.3 33.3 
Insured 13896 66.7 66.7 100.0 
Total 20822 100.0 100.0  
Other opiates/synthetics reported at admission 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Substance not reported 16686 80.1 80.1 80.1 
Substance reported 4136 19.9 19.9 100.0 
Total 20822 100.0 100.0  
 
Reason to group 
 Frequency Percent Valid Percent 
Cumulative 
Percent 
Valid Treatment not completed 14631 70.3 70.3 70.3 
Treatment completed 6191 29.7 29.7 100.0 






Case Processing Summary 
 
Cases 
Valid Missing Total 
N Percent N Percent N Percent 
Other opiates/synthetics 
reported at admission * 
Education 
20822 100.0% 0 0.0% 20822 100.0% 
Other opiates/synthetics 
reported at admission * 
Marital status 
20822 100.0% 0 0.0% 20822 100.0% 
Other opiates/synthetics 
reported at admission * 
EMPLOY group 
20822 100.0% 0 0.0% 20822 100.0% 
Other opiates/synthetics 
reported at admission * 
Biologic sex 
20822 100.0% 0 0.0% 20822 100.0% 
Other opiates/synthetics 
reported at admission * 
Race to group 
20822 100.0% 0 0.0% 20822 100.0% 
Other opiates/synthetics 
reported at admission * 
AGE Group 










Pearson Chi-Square 18.028a 4 .001 
Likelihood Ratio 18.245 4 .001 
Linear-by-Linear Association 11.821 1 .001 












Nominal by Nominal Phi .029 .001 
Cramer's V .029 .001 





















Count 3501 222 2267 10696 16686 
Expected 
Count 




Count 975 62 661 2438 4136 
Expected 
Count 
889.1 56.4 581.6 2608.9 4136.
0 
Total Count 4476 284 2928 13134 20822 
Expected 
Count 









Pearson Chi-Square 38.540a 3 .000 
Likelihood Ratio 38.092 3 .000 
Linear-by-Linear Association 24.908 1 .000 




a. 0 cells (0.0%) have expected count less than 5. The minimum 







Nominal by Nominal Phi .043 .000 
Cramer's V .043 .000 





















Count 2716 6610 1926 5434 16686 
Expected 
Count 




Count 682 1869 429 1156 4136 
Expected 
Count 
675.0 1684.2 467.8 1309.0 4136.0 
Total Count 3398 8479 2355 6590 20822 
Expected 
Count 









Pearson Chi-Square 51.717a 3 .000 
Likelihood Ratio 51.846 3 .000 
Linear-by-Linear Association 31.059 1 .000 












Nominal by Nominal Phi .050 .000 
Cramer's V .050 .000 






Total Male Female 
Other opiates/synthetics 
reported at admission 
Substance not reported Count 10333 6353 16686 
Expected Count 9996.2 6689.8 16686.0 
Substance reported Count 2141 1995 4136 
Expected Count 2477.8 1658.2 4136.0 
Total Count 12474 8348 20822 












Pearson Chi-Square 142.480a 1 .000   
Continuity Correctionb 142.058 1 .000   
Likelihood Ratio 140.663 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
142.473 1 .000 
  




a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is 1658.21. 



















Count 73 2743 872 12998 16686 
Expected 
Count 






Count 7 154 154 3821 4136 
Expected 
Count 
15.9 575.4 203.8 3340.9 4136.0 
Total Count 80 2897 1026 16819 20822 
Expected 
Count 












Pearson Chi-Square 492.672a 3 .000 
Likelihood Ratio 616.124 3 .000 
Linear-by-Linear Association 485.341 1 .000 
N of Valid Cases 20822   
a. 0 cells (0.0%) have expected count less than 5. The minimum 










Nominal by Nominal Phi .154 .000 
Cramer's V .154 .000 















Count 1076 3157 4141 8312 16686 
Expected 
Count 




Count 106 427 1059 2544 4136 
Expected 
Count 
234.8 711.9 1032.9 2156.4 4136.0 
Total Count 1182 3584 5200 10856 20822 
Expected 
Count 












Pearson Chi-Square 318.205a 3 .000 
Likelihood Ratio 350.593 3 .000 
Linear-by-Linear Association 301.720 1 .000 




a. 0 cells (0.0%) have expected count less than 5. The minimum expected 







Nominal by Nominal Phi .124 .000 
Cramer's V .124 .000 











Reason to groupa B 
Std. 
Error Wald df Sig. Exp(B) 
95% Confidence 







Intercept .982 .019 2657.3
89 
1 .000 





1 .000 .704 .662 .749 
[Health to 
group=1] 




Case Processing Summary 
 
 N Marginal Percentage 
Reason to group Treatment not completed 14631 70.3% 
Treatment completed 6191 29.7% 
Health to group Uninsured 6926 33.3% 
Insured 13896 66.7% 
Education Primary 782 3.8% 
Secondary 4990 24.0% 
College 4235 20.3% 
Graduate 586 2.8% 
High School 10229 49.1% 
Marital status Divorced, widowed 4476 21.5% 
Separated 284 1.4% 
Now  married 2928 14.1% 
Never married 13134 63.1% 
EMPLOY group Not in labor force 3398 16.3% 
Unemployed 8479 40.7% 
Part-time 2355 11.3% 
Full-time 6590 31.6% 
Biologic sex Male 12474 59.9% 
Female 8348 40.1% 
Race to group Native Americans 80 0.4% 
Blacks or African Americans 2897 13.9% 
All Others 1026 4.9% 
Whites 16819 80.8% 
AGE Group 55 and older 1182 5.7% 
45-54 3584 17.2% 
35-44 5200 25.0% 
18-34 10856 52.1% 
Valid 20822 100.0% 
Missing 0  
Total 20822  
Subpopulation 1878a  







Reason to groupa B 
Std. 
Error Wald df Sig. Exp(B) 








Intercept .712 .043 277.11
6 
1 .000 
   
[Health to 
group=0] 
-.325 .033 99.701 1 .000 .722 .678 .770 
[Health to 
group=1] 
0b . . 0 . . . . 
[Education=1] .150 .087 3.007 1 .083 1.162 .981 1.378 
[Education=2] .068 .039 2.990 1 .084 1.070 .991 1.155 
[Education=3] -.089 .040 4.835 1 .028 .915 .846 .990 
[Education=4] -.302 .090 11.371 1 .001 .739 .620 .881 
[Education=5] 0b . . 0 . . . . 
[Marital 
status=1] 
.131 .040 10.502 1 .001 1.140 1.053 1.234 
[Marital 
status=2] 
-.019 .133 .020 1 .888 .982 .757 1.273 
[Marital 
status=3] 
-.008 .045 .030 1 .863 .992 .908 1.084 
[Marital 
status=4] 










1 .000 1.801 1.677 1.934 
[EMPLOY 
group=3] 
.331 .052 39.910 1 .000 1.392 1.256 1.542 
[EMPLOY 
group=4] 
0b . . 0 . . . . 
[Biologic sex=1] -.049 .033 2.237 1 .135 .952 .893 1.015 






-.213 .239 .795 1 .373 .808 .506 1.291 
[Race to 
group=2] 
.061 .046 1.778 1 .182 1.063 .972 1.162 
[Race to 
group=3] 
-.148 .070 4.472 1 .034 .863 .753 .989 
[Race to 
group=4] 
0b . . 0 . . . . 
[AGE Group=1] -.676 .069 96.930 1 .000 .509 .445 .582 
[AGE Group=2] -.191 .043 19.408 1 .000 .826 .759 .899 
[AGE Group=3] -.093 .039 5.789 1 .016 .911 .845 .983 
[AGE Group=4] 0b . . 0 . . . . 
a. The reference category is: Treatment completed. 
b. This parameter is set to zero because it is redundant. 
 
